mp:VDraft3.0.0 testgegevens medicatiegegevensMGSMGO TA addendum: verschil tussen versies
(ada-2-wiki with updated ada 02-07-2024c) |
|||
| (7 tussenliggende versies door 5 gebruikers niet weergegeven) | |||
| Regel 12: | Regel 12: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1|| || || MBH_300_start_eind<br/>MBH_300_start_duur<br/>MBH_300_chronisch<br/>MBH_300_start_duur2<br/>MBH_300_dosis_stuks|| MBH_300_start_eind_TA<br/>MBH_300_start_duur_TA<br/>MBH_300_chronisch_TA<br/>MBH_300_start_duur2_TA<br/>MBH_300_dosis_stuks_TA | + | |1|| || || MBH_300_start_eind-tmgs<br/>MBH_300_start_duur-tmgs<br/>MBH_300_chronisch-tmgs<br/>MBH_300_start_duur2-tmgs<br/>MBH_300_dosis_stuks-tmgs<br/>MBH_300_start_criterium-tmgs|| MBH_300_start_eind_TA-tmgs<br/>MBH_300_start_duur_TA-tmgs<br/>MBH_300_chronisch_TA-tmgs<br/>MBH_300_start_duur2_TA-tmgs<br/>MBH_300_dosis_stuks_TA-tmgs<br/>MBH_300_start_criterium_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2|| || || MBH_300_aanvullendeinstructie<br/>MBH_300_toelichting<br/>MBH_300_redenvanvoorschrijven<br/>MBH_300_aanvullendeinformatiewensen<br/>MBH_300_Toedieningsweg|| MBH_300_aanvullendeinstructie_TA<br/>MBH_300_toelichting_TA<br/>MBH_300_redenvanvoorschrijven_TA<br/>MBH_300_aanvullendeinformatiewensen_TA<br/>MBH_300_Toedieningsweg_TA | + | |2|| || || MBH_300_aanvullendeinstructie-tmgs<br/>MBH_300_toelichting-tmgs<br/>MBH_300_redenvanvoorschrijven-tmgs<br/>MBH_300_aanvullendeinformatiewensen-tmgs<br/>MBH_300_Toedieningsweg-tmgs|| MBH_300_aanvullendeinstructie_TA-tmgs<br/>MBH_300_toelichting_TA-tmgs<br/>MBH_300_redenvanvoorschrijven_TA-tmgs<br/>MBH_300_aanvullendeinformatiewensen_TA-tmgs<br/>MBH_300_Toedieningsweg_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3|| || || MBH_300_stoppen<br/>MBH_300_wijzigen_verhoging<br/>MBH_300_wijzigen_verlaging<br/>MBH_300_onderbreken<br/>MBH_300_TAwijzigen<br/>MBH_300_annuleren<br/>MBH_300_stoppen_parallele_TA<br/>MBH_300_MTDopschorten<br/>mbh_300_AfwijkendeToediening<br/>MBH_300_wijzigen_correctie<br/>MBH_300_CorrectieToediening || MBH_300_stoppen_TA_start<br/>MBH_300_stoppen_TA_staken<br/>MBH_300_wijzigen_verhoging_TA_start<br/>MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE<br/>MBH_300_wijzigen_verhoging_TA_techstaken<br/>MBH_300_wijzigen_verlaging_TA_start<br/>MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE<br/>MBH_300_wijzigen_verlaging_TA_techstaken<br/>MBH_300_onderbreken_TA_start<br/>MBH_300_onderbreken_TA_onderbreken<br/>MBH_300_TAwijzigen_TA_start<br/>MBH_300_TAwijzigen_TA_techstaken<br/>MBH_300_TAwijzigen_TA_anderePRK<br/>MBH_300_annuleren_TA_starten<br/>MBH_300_annuleren_TA_geannuleerd<br/>MBH_300_stoppen_parallele_TA_TA_start_GDS<br/>MBH_300_stoppen_parallele_TA_TA_start_zonodig<br/>MBH_300_stoppen_parallele_TA_TA_stop_zonodig<br/>MBH_300_stoppen_parallele_TA_TA_start2_zonodig<br/>MBH_300_MTDopschorten_TA<br/>mbh_300_AfwijkendeToediening_TA<br/>MBH_300_wijzigen_correctie_TA<br/>MBH_300_wijzigen_correctie_TA_stopTA<br/>MBH_300_wijzigen_correctie_TA_correctieTA<br/>MBH_300_CorrectieToediening_TA | + | |3|| || || MBH_300_stoppen-tmgs<br/>MBH_300_wijzigen_verhoging-tmgs<br/>MBH_300_wijzigen_verlaging-tmgs<br/>MBH_300_onderbreken-tmgs<br/>MBH_300_TAwijzigen-tmgs<br/>MBH_300_annuleren-tmgs<br/>MBH_300_stoppen_parallele_TA-tmgs<br/>MBH_300_MTDopschorten-tmgs<br/>mbh_300_AfwijkendeToediening-tmgs<br/>MBH_300_wijzigen_correctie-tmgs<br/>MBH_300_CorrectieToediening -tmgs|| MBH_300_stoppen_TA_start-tmgs<br/>MBH_300_stoppen_TA_staken-tmgs<br/>MBH_300_wijzigen_verhoging_TA_start-tmgs<br/>MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs<br/>MBH_300_wijzigen_verhoging_TA_techstaken-tmgs<br/>MBH_300_wijzigen_verlaging_TA_start-tmgs<br/>MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs<br/>MBH_300_wijzigen_verlaging_TA_techstaken-tmgs<br/>MBH_300_onderbreken_TA_start-tmgs<br/>MBH_300_onderbreken_TA_onderbreken-tmgs<br/>MBH_300_TAwijzigen_TA_start-tmgs<br/>MBH_300_TAwijzigen_TA_techstaken-tmgs<br/>MBH_300_TAwijzigen_TA_anderePRK-tmgs<br/>MBH_300_annuleren_TA_starten-tmgs<br/>MBH_300_annuleren_TA_geannuleerd-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs<br/>MBH_300_MTDopschorten_TA-tmgs<br/>mbh_300_AfwijkendeToediening_TA-tmgs<br/>MBH_300_wijzigen_correctie_TA-tmgs<br/>MBH_300_wijzigen_correctie_TA_stopTA-tmgs<br/>MBH_300_wijzigen_correctie_TA_correctieTA-tmgs<br/>MBH_300_CorrectieToediening_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6|| || || MBH_300_variabelefrequentie<br/>MBH_300_interval<br/>MBH_300_variabelehoeveelheid<br/>MBH_300_zonderkeerdosis<br/>MBH_300_bijzonderekeerdosis<br/>MBH_300_variabelehoeveelheid2<br/>MBH_300_tijdstippen_flexibel<br/>MBH_300_weekdagen<br/>MBH_300_dagdeel<br/>MBH_300_cyclischschema<br/>MBH_300_afbouwschema<br/>MBH_300_variabelehoeveelheidenmaximum<br/>MBH_300_toedieningssnelheid<br/>MBH_300_toedieningsduur<br/>MBH_300_zonodig<br/>MBH_300_tijdstippen_niet_flexibel|| MBH_300_variabelefrequentie_TA<br/>MBH_300_interval_TA<br/>MBH_300_variabelehoeveelheid_TA<br/>MBH_300_zonderkeerdosis_TA<br/>MBH_300_bijzonderekeerdosis_TA<br/>MBH_300_variabelehoeveelheid2_TA<br/>MBH_300_tijdstippen_flexibel_TA<br/>MBH_300_weekdagen_TA<br/>MBH_300_dagdeel_TA<br/>MBH_300_cyclischschema_TA<br/>MBH_300_afbouwschema_TA<br/>MBH_300_variabelehoeveelheidenmaximum_TA<br/>MBH_300_toedieningssnelheid_TA<br/>MBH_300_toedieningsduur_TA<br/>MBH_300_zonodig_TA<br/>MBH_300_tijdstippen_niet_flexibel_TA | + | |6|| || || MBH_300_variabelefrequentie-tmgs<br/>MBH_300_interval-tmgs<br/>MBH_300_variabelehoeveelheid-tmgs<br/>MBH_300_zonderkeerdosis-tmgs<br/>MBH_300_bijzonderekeerdosis-tmgs<br/>MBH_300_variabelehoeveelheid2-tmgs<br/>MBH_300_tijdstippen_flexibel-tmgs<br/>MBH_300_weekdagen-tmgs<br/>MBH_300_dagdeel-tmgs<br/>MBH_300_cyclischschema-tmgs<br/>MBH_300_afbouwschema-tmgs<br/>MBH_300_variabelehoeveelheidenmaximum-tmgs<br/>MBH_300_toedieningssnelheid-tmgs<br/>MBH_300_toedieningsduur-tmgs<br/>MBH_300_zonodig-tmgs<br/>MBH_300_tijdstippen_niet_flexibel-tmgs<br/>MBH_300_redundantefrequentie-tmgs|| MBH_300_variabelefrequentie_TA-tmgs<br/>MBH_300_interval_TA-tmgs<br/>MBH_300_variabelehoeveelheid_TA-tmgs<br/>MBH_300_zonderkeerdosis_TA-tmgs<br/>MBH_300_bijzonderekeerdosis_TA-tmgs<br/>MBH_300_variabelehoeveelheid2_TA-tmgs<br/>MBH_300_tijdstippen_flexibel_TA-tmgs<br/>MBH_300_weekdagen_TA-tmgs<br/>MBH_300_dagdeel_TA-tmgs<br/>MBH_300_cyclischschema_TA-tmgs<br/>MBH_300_afbouwschema_TA-tmgs<br/>MBH_300_variabelehoeveelheidenmaximum_TA-tmgs<br/>MBH_300_toedieningssnelheid_TA-tmgs<br/>MBH_300_toedieningsduur_TA-tmgs<br/>MBH_300_zonodig_TA-tmgs<br/>MBH_300_tijdstippen_niet_flexibel_TA-tmgs<br/>MBH_300_redundantefrequentie_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7|| || || MBH_300_magistraalalleingredienten<br/>MBH_300_magistraalactieveingredient<br/>MBH_300_magistraal90miljoennr<br/>MBH_300_vrijetekstproduct|| MBH_300_magistraalalleingredienten_TA<br/>MBH_300_magistraalactieveingredient_TA<br/>MBH_300_magistraal90miljoennr_TA<br/>MBH_300_vrijetekstproduct_TA | + | |7|| || || MBH_300_magistraalalleingredienten-tmgs<br/>MBH_300_magistraalactieveingredient-tmgs<br/>MBH_300_magistraal90miljoennr-tmgs<br/>MBH_300_vrijetekstproduct-tmgs|| MBH_300_magistraalalleingredienten_TA-tmgs<br/>MBH_300_magistraalactieveingredient_TA-tmgs<br/>MBH_300_magistraal90miljoennr_TA-tmgs<br/>MBH_300_vrijetekstproduct_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |10|| || || MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_TA | + | |10|| || || MBH_300_ZINRvoorschrijven-tmgs|| MBH_300_ZINRvoorschrijven_TA-tmgs |
|} | |} | ||
<section end=overview-MGB- /> | <section end=overview-MGB- /> | ||
| Regel 31: | Regel 31: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_300_start_eind|| MBH_300_start_eind_TA | + | |1.1*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_300_start_eind-tmgs|| MBH_300_start_eind_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken)</div>|| MBH_300_start_duur|| MBH_300_start_duur_TA | + | |1.2a*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken)</div>|| MBH_300_start_duur-tmgs|| MBH_300_start_duur_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)</div>|| MBH_300_start_duur2|| MBH_300_start_duur2_TA | + | |1.2b*|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur).|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)</div>|| MBH_300_start_duur2-tmgs|| MBH_300_start_duur2_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.3|| || <div>Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)</div>|| MBH_300_chronisch|| MBH_300_chronisch_TA | + | |1.3|| || <div>Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)</div>|| MBH_300_chronisch-tmgs|| MBH_300_chronisch_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.4|| || <div>Toedieningsafspraak met eenheid 'dosis/stuks'</div>|| MBH_300_dosis_stuks|| MBH_300_dosis_stuks_TA | + | |1.4|| || <div>Toedieningsafspraak met eenheid 'dosis/stuks'</div>|| MBH_300_dosis_stuks-tmgs|| MBH_300_dosis_stuks_TA-tmgs |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |1.6|| Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode criterium ingevoerd kan worden|| Toedieningsafspraak met gebruiksperiode criterium|| MBH_300_start_criterium-tmgs|| MBH_300_start_criterium_TA-tmgs | ||
|} | |} | ||
<section end=overview-MGB-1 /> | <section end=overview-MGB-1 /> | ||
| Regel 48: | Regel 50: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie|| MBH_300_aanvullendeinstructie|| MBH_300_aanvullendeinstructie_TA | + | |2.1|| Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje)|| Aanvullende instructie|| MBH_300_aanvullendeinstructie-tmgs|| MBH_300_aanvullendeinstructie_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.2|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_300_toelichting|| MBH_300_toelichting_TA | + | |2.2|| Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden|| Toelichting|| MBH_300_toelichting-tmgs|| MBH_300_toelichting_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven|| MBH_300_redenvanvoorschrijven|| MBH_300_redenvanvoorschrijven_TA | + | |2.3|| Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld.|| Reden van voorschrijven|| MBH_300_redenvanvoorschrijven-tmgs|| MBH_300_redenvanvoorschrijven_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.4|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen|| MBH_300_aanvullendeinformatiewensen_TA | + | |2.4|| Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen-tmgs|| MBH_300_aanvullendeinformatiewensen_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.5|| Maak screenshot(s) waarop de toelichting zichtbaar is|| Toedieningsweg|| MBH_300_Toedieningsweg|| MBH_300_Toedieningsweg_TA | + | |2.5|| Maak screenshot(s) waarop de toelichting zichtbaar is|| Toedieningsweg|| MBH_300_Toedieningsweg-tmgs|| MBH_300_Toedieningsweg_TA-tmgs |
|} | |} | ||
<section end=overview-MGB-2 /> | <section end=overview-MGB-2 /> | ||
| Regel 65: | Regel 67: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.1|| || <div>Stop-toedieningsafspraak, met reden staken</div>|| MBH_300_stoppen|| MBH_300_stoppen_TA_start<br/>MBH_300_stoppen_TA_staken | + | |3.1|| || <div>Stop-toedieningsafspraak, met reden staken</div>|| MBH_300_stoppen-tmgs|| MBH_300_stoppen_TA_start-tmgs<br/>MBH_300_stoppen_TA_staken-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging toedieningsafspraak, met reden wijziging<br/>|| MBH_300_wijzigen_verhoging|| MBH_300_wijzigen_verhoging_TA_start<br/>MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE<br/>MBH_300_wijzigen_verhoging_TA_techstaken | + | |3.2|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| Wijziging toedieningsafspraak, met reden wijziging<br/>|| MBH_300_wijzigen_verhoging-tmgs|| MBH_300_wijzigen_verhoging_TA_start-tmgs<br/>MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs<br/>MBH_300_wijzigen_verhoging_TA_techstaken-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Wijziging toedieningsafspraak, met reden wijziging</div>|| MBH_300_wijzigen_verlaging|| MBH_300_wijzigen_verlaging_TA_start<br/>MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE<br/>MBH_300_wijzigen_verlaging_TA_techstaken | + | |3.3|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Wijziging toedieningsafspraak, met reden wijziging</div>|| MBH_300_wijzigen_verlaging-tmgs|| MBH_300_wijzigen_verlaging_TA_start-tmgs<br/>MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs<br/>MBH_300_wijzigen_verlaging_TA_techstaken-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.4|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Onderbreken toedieningsafspraak </div>|| MBH_300_onderbreken|| MBH_300_onderbreken_TA_start<br/>MBH_300_onderbreken_TA_onderbreken | + | |3.4|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt|| <div>Onderbreken toedieningsafspraak </div>|| MBH_300_onderbreken-tmgs|| MBH_300_onderbreken_TA_start-tmgs<br/>MBH_300_onderbreken_TA_onderbreken-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.5|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt</span></div>|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Tweede MVE ivm TA met nieuwe PRK. </span></div>|| MBH_300_TAwijzigen|| MBH_300_TAwijzigen_TA_start<br/>MBH_300_TAwijzigen_TA_techstaken<br/>MBH_300_TAwijzigen_TA_anderePRK | + | |3.5|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt</span></div>|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Tweede MVE ivm TA met nieuwe PRK. </span></div>|| MBH_300_TAwijzigen-tmgs|| MBH_300_TAwijzigen_TA_start-tmgs<br/>MBH_300_TAwijzigen_TA_techstaken-tmgs<br/>MBH_300_TAwijzigen_TA_anderePRK-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.6|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt.|| Annuleren toedieningsafspraak|| MBH_300_annuleren|| MBH_300_annuleren_TA_starten<br/>MBH_300_annuleren_TA_geannuleerd | + | |3.6|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt.|| Annuleren toedieningsafspraak|| MBH_300_annuleren-tmgs|| MBH_300_annuleren_TA_starten-tmgs<br/>MBH_300_annuleren_TA_geannuleerd-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.7|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt.|| Stoppen van een TA bij twee parallelle TA's|| MBH_300_stoppen_parallele_TA|| MBH_300_stoppen_parallele_TA_TA_start_GDS<br/>MBH_300_stoppen_parallele_TA_TA_start_zonodig<br/>MBH_300_stoppen_parallele_TA_TA_stop_zonodig<br/>MBH_300_stoppen_parallele_TA_TA_start2_zonodig | + | |3.7|| Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt.|| Stoppen van een TA bij twee parallelle TA's|| MBH_300_stoppen_parallele_TA-tmgs|| MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.10|| || TA waarin een correctie plaatsvindt|| MBH_300_wijzigen_correctie|| MBH_300_wijzigen_correctie_TA<br/>MBH_300_wijzigen_correctie_TA_stopTA<br/>MBH_300_wijzigen_correctie_TA_correctieTA | + | |3.10|| || TA waarin een correctie plaatsvindt|| MBH_300_wijzigen_correctie-tmgs|| MBH_300_wijzigen_correctie_TA-tmgs<br/>MBH_300_wijzigen_correctie_TA_stopTA-tmgs<br/>MBH_300_wijzigen_correctie_TA_correctieTA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.11|| || TA waaronder een MTD wordt opgeschort|| MBH_300_MTDopschorten|| MBH_300_MTDopschorten_TA | + | |3.11|| || TA waaronder een MTD wordt opgeschort|| MBH_300_MTDopschorten-tmgs|| MBH_300_MTDopschorten_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.12|| || TA waaronder een MTD een afwijkende toegediende hoeveelheid heeft|| mbh_300_AfwijkendeToediening|| mbh_300_AfwijkendeToediening_TA | + | |3.12|| || TA waaronder een MTD een afwijkende toegediende hoeveelheid heeft|| mbh_300_AfwijkendeToediening-tmgs|| mbh_300_AfwijkendeToediening_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.13|| || TA waaronder een MTD een correctie toediening heeft|| MBH_300_CorrectieToediening || MBH_300_CorrectieToediening_TA | + | |3.13|| || TA waaronder een MTD een correctie toediening heeft|| MBH_300_CorrectieToediening -tmgs|| MBH_300_CorrectieToediening_TA-tmgs |
|} | |} | ||
<section end=overview-MGB-3 /> | <section end=overview-MGB-3 /> | ||
| Regel 94: | Regel 96: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6.1|| || Variabele frequentie|| MBH_300_variabelefrequentie|| MBH_300_variabelefrequentie_TA | + | |6.1|| || Variabele frequentie|| MBH_300_variabelefrequentie-tmgs|| MBH_300_variabelefrequentie_TA-tmgs |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |6.2|| || Interval|| MBH_300_interval-tmgs|| MBH_300_interval_TA-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.3|| || Variabele hoeveelheid (1)|| MBH_300_variabelehoeveelheid-tmgs|| MBH_300_variabelehoeveelheid_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.4|| || Zonder keerdosis|| MBH_300_zonderkeerdosis-tmgs|| MBH_300_zonderkeerdosis_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.5|| || Bijzondere keerdosis|| MBH_300_bijzonderekeerdosis-tmgs|| MBH_300_bijzonderekeerdosis_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.6|| || Variabele hoeveelheid (2)|| MBH_300_variabelehoeveelheid2-tmgs|| MBH_300_variabelehoeveelheid2_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.7a|| Maak screenshot(s) waarop zichtbaar is dat tijdstip gekozen kan worden|| Tijdstippen flexibel|| MBH_300_tijdstippen_flexibel-tmgs|| MBH_300_tijdstippen_flexibel_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.7b|| || Tijdstippen niet flexibel|| MBH_300_tijdstippen_niet_flexibel-tmgs|| MBH_300_tijdstippen_niet_flexibel_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.8|| Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden|| Weekdagen|| MBH_300_weekdagen-tmgs|| MBH_300_weekdagen_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.9|| Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden|| Dagdeel|| MBH_300_dagdeel-tmgs|| MBH_300_dagdeel_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.10|| Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden|| Cyclisch schema|| MBH_300_cyclischschema-tmgs|| MBH_300_cyclischschema_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.11|| Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden|| Afbouw schema en doseerduur|| MBH_300_afbouwschema-tmgs|| MBH_300_afbouwschema_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.12|| || Variabele hoeveelheid en maximum|| MBH_300_variabelehoeveelheidenmaximum-tmgs|| MBH_300_variabelehoeveelheidenmaximum_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.13|| || Toedieningssnelheid|| MBH_300_toedieningssnelheid-tmgs|| MBH_300_toedieningssnelheid_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.14|| || Toedieningsduur|| MBH_300_toedieningsduur-tmgs|| MBH_300_toedieningsduur_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.15|| Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid)|| Zo nodig|| MBH_300_zonodig-tmgs|| MBH_300_zonodig_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.16|| || Redundante frequentie|| MBH_300_redundantefrequentie-tmgs|| MBH_300_redundantefrequentie_TA-tmgs |
|} | |} | ||
<section end=overview-MGB-6 /> | <section end=overview-MGB-6 /> | ||
| Regel 133: | Regel 137: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_TA | + | |7.1|| Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-tmgs|| MBH_300_magistraalalleingredienten_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_TA | + | |7.2|| Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-tmgs|| MBH_300_magistraalactieveingredient_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr|| MBH_300_magistraal90miljoennr_TA | + | |7.3|| Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-tmgs|| MBH_300_magistraal90miljoennr_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.4|| Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt|| Vrije tekst product|| MBH_300_vrijetekstproduct|| MBH_300_vrijetekstproduct_TA | + | |7.4|| Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt|| Vrije tekst product|| MBH_300_vrijetekstproduct-tmgs|| MBH_300_vrijetekstproduct_TA-tmgs |
|} | |} | ||
<section end=overview-MGB-7 /> | <section end=overview-MGB-7 /> | ||
| Regel 148: | Regel 152: | ||
| Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |10.1|| || ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_TA | + | |10.1|| || ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven-tmgs|| MBH_300_ZINRvoorschrijven_TA-tmgs |
|} | |} | ||
<section end=overview-MGB-10 /> | <section end=overview-MGB-10 /> | ||
| Regel 159: | Regel 163: | ||
| Scenario|| Beschrijving|| MBH id|| TA id | | Scenario|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1|| || MBH_300_start_eind<br/>MBH_300_start_duur<br/>MBH_300_chronisch<br/>MBH_300_start_duur2<br/>MBH_300_dosis_stuks|| MBH_300_start_eind_TA<br/>MBH_300_start_duur_TA<br/>MBH_300_chronisch_TA<br/>MBH_300_start_duur2_TA<br/>MBH_300_dosis_stuks_TA | + | |1|| || MBH_300_start_eind-tmgs<br/>MBH_300_start_duur-tmgs<br/>MBH_300_chronisch-tmgs<br/>MBH_300_start_duur2-tmgs<br/>MBH_300_dosis_stuks-tmgs<br/>MBH_300_start_criterium-tmgs|| MBH_300_start_eind_TA-tmgs<br/>MBH_300_start_duur_TA-tmgs<br/>MBH_300_chronisch_TA-tmgs<br/>MBH_300_start_duur2_TA-tmgs<br/>MBH_300_dosis_stuks_TA-tmgs<br/>MBH_300_start_criterium_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2|| || MBH_300_aanvullendeinstructie<br/>MBH_300_toelichting<br/>MBH_300_redenvanvoorschrijven<br/>MBH_300_aanvullendeinformatiewensen<br/>MBH_300_Toedieningsweg|| MBH_300_aanvullendeinstructie_TA<br/>MBH_300_toelichting_TA<br/>MBH_300_redenvanvoorschrijven_TA<br/>MBH_300_aanvullendeinformatiewensen_TA<br/>MBH_300_Toedieningsweg_TA | + | |2|| || MBH_300_aanvullendeinstructie-tmgs<br/>MBH_300_toelichting-tmgs<br/>MBH_300_redenvanvoorschrijven-tmgs<br/>MBH_300_aanvullendeinformatiewensen-tmgs<br/>MBH_300_Toedieningsweg-tmgs|| MBH_300_aanvullendeinstructie_TA-tmgs<br/>MBH_300_toelichting_TA-tmgs<br/>MBH_300_redenvanvoorschrijven_TA-tmgs<br/>MBH_300_aanvullendeinformatiewensen_TA-tmgs<br/>MBH_300_Toedieningsweg_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3|| || MBH_300_stoppen<br/>MBH_300_wijzigen_verhoging<br/>MBH_300_wijzigen_verlaging<br/>MBH_300_onderbreken<br/>MBH_300_TAwijzigen<br/>MBH_300_annuleren<br/>MBH_300_stoppen_parallele_TA<br/>MBH_300_MTDopschorten<br/>mbh_300_AfwijkendeToediening<br/>MBH_300_wijzigen_correctie<br/>MBH_300_CorrectieToediening || MBH_300_stoppen_TA_start<br/>MBH_300_stoppen_TA_staken<br/>MBH_300_wijzigen_verhoging_TA_start<br/>MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE<br/>MBH_300_wijzigen_verhoging_TA_techstaken<br/>MBH_300_wijzigen_verlaging_TA_start<br/>MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE<br/>MBH_300_wijzigen_verlaging_TA_techstaken<br/>MBH_300_onderbreken_TA_start<br/>MBH_300_onderbreken_TA_onderbreken<br/>MBH_300_TAwijzigen_TA_start<br/>MBH_300_TAwijzigen_TA_techstaken<br/>MBH_300_TAwijzigen_TA_anderePRK<br/>MBH_300_annuleren_TA_starten<br/>MBH_300_annuleren_TA_geannuleerd<br/>MBH_300_stoppen_parallele_TA_TA_start_GDS<br/>MBH_300_stoppen_parallele_TA_TA_start_zonodig<br/>MBH_300_stoppen_parallele_TA_TA_stop_zonodig<br/>MBH_300_stoppen_parallele_TA_TA_start2_zonodig<br/>MBH_300_MTDopschorten_TA<br/>mbh_300_AfwijkendeToediening_TA<br/>MBH_300_wijzigen_correctie_TA<br/>MBH_300_wijzigen_correctie_TA_stopTA<br/>MBH_300_wijzigen_correctie_TA_correctieTA<br/>MBH_300_CorrectieToediening_TA | + | |3|| || MBH_300_stoppen-tmgs<br/>MBH_300_wijzigen_verhoging-tmgs<br/>MBH_300_wijzigen_verlaging-tmgs<br/>MBH_300_onderbreken-tmgs<br/>MBH_300_TAwijzigen-tmgs<br/>MBH_300_annuleren-tmgs<br/>MBH_300_stoppen_parallele_TA-tmgs<br/>MBH_300_MTDopschorten-tmgs<br/>mbh_300_AfwijkendeToediening-tmgs<br/>MBH_300_wijzigen_correctie-tmgs<br/>MBH_300_CorrectieToediening -tmgs|| MBH_300_stoppen_TA_start-tmgs<br/>MBH_300_stoppen_TA_staken-tmgs<br/>MBH_300_wijzigen_verhoging_TA_start-tmgs<br/>MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs<br/>MBH_300_wijzigen_verhoging_TA_techstaken-tmgs<br/>MBH_300_wijzigen_verlaging_TA_start-tmgs<br/>MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs<br/>MBH_300_wijzigen_verlaging_TA_techstaken-tmgs<br/>MBH_300_onderbreken_TA_start-tmgs<br/>MBH_300_onderbreken_TA_onderbreken-tmgs<br/>MBH_300_TAwijzigen_TA_start-tmgs<br/>MBH_300_TAwijzigen_TA_techstaken-tmgs<br/>MBH_300_TAwijzigen_TA_anderePRK-tmgs<br/>MBH_300_annuleren_TA_starten-tmgs<br/>MBH_300_annuleren_TA_geannuleerd-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs<br/>MBH_300_MTDopschorten_TA-tmgs<br/>mbh_300_AfwijkendeToediening_TA-tmgs<br/>MBH_300_wijzigen_correctie_TA-tmgs<br/>MBH_300_wijzigen_correctie_TA_stopTA-tmgs<br/>MBH_300_wijzigen_correctie_TA_correctieTA-tmgs<br/>MBH_300_CorrectieToediening_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6|| || MBH_300_variabelefrequentie<br/>MBH_300_interval<br/>MBH_300_variabelehoeveelheid<br/>MBH_300_zonderkeerdosis<br/>MBH_300_bijzonderekeerdosis<br/>MBH_300_variabelehoeveelheid2<br/>MBH_300_tijdstippen_flexibel<br/>MBH_300_weekdagen<br/>MBH_300_dagdeel<br/>MBH_300_cyclischschema<br/>MBH_300_afbouwschema<br/>MBH_300_variabelehoeveelheidenmaximum<br/>MBH_300_toedieningssnelheid<br/>MBH_300_toedieningsduur<br/>MBH_300_zonodig<br/>MBH_300_tijdstippen_niet_flexibel|| MBH_300_variabelefrequentie_TA<br/>MBH_300_interval_TA<br/>MBH_300_variabelehoeveelheid_TA<br/>MBH_300_zonderkeerdosis_TA<br/>MBH_300_bijzonderekeerdosis_TA<br/>MBH_300_variabelehoeveelheid2_TA<br/>MBH_300_tijdstippen_flexibel_TA<br/>MBH_300_weekdagen_TA<br/>MBH_300_dagdeel_TA<br/>MBH_300_cyclischschema_TA<br/>MBH_300_afbouwschema_TA<br/>MBH_300_variabelehoeveelheidenmaximum_TA<br/>MBH_300_toedieningssnelheid_TA<br/>MBH_300_toedieningsduur_TA<br/>MBH_300_zonodig_TA<br/>MBH_300_tijdstippen_niet_flexibel_TA | + | |6|| || MBH_300_variabelefrequentie-tmgs<br/>MBH_300_interval-tmgs<br/>MBH_300_variabelehoeveelheid-tmgs<br/>MBH_300_zonderkeerdosis-tmgs<br/>MBH_300_bijzonderekeerdosis-tmgs<br/>MBH_300_variabelehoeveelheid2-tmgs<br/>MBH_300_tijdstippen_flexibel-tmgs<br/>MBH_300_weekdagen-tmgs<br/>MBH_300_dagdeel-tmgs<br/>MBH_300_cyclischschema-tmgs<br/>MBH_300_afbouwschema-tmgs<br/>MBH_300_variabelehoeveelheidenmaximum-tmgs<br/>MBH_300_toedieningssnelheid-tmgs<br/>MBH_300_toedieningsduur-tmgs<br/>MBH_300_zonodig-tmgs<br/>MBH_300_tijdstippen_niet_flexibel-tmgs<br/>MBH_300_redundantefrequentie-tmgs|| MBH_300_variabelefrequentie_TA-tmgs<br/>MBH_300_interval_TA-tmgs<br/>MBH_300_variabelehoeveelheid_TA-tmgs<br/>MBH_300_zonderkeerdosis_TA-tmgs<br/>MBH_300_bijzonderekeerdosis_TA-tmgs<br/>MBH_300_variabelehoeveelheid2_TA-tmgs<br/>MBH_300_tijdstippen_flexibel_TA-tmgs<br/>MBH_300_weekdagen_TA-tmgs<br/>MBH_300_dagdeel_TA-tmgs<br/>MBH_300_cyclischschema_TA-tmgs<br/>MBH_300_afbouwschema_TA-tmgs<br/>MBH_300_variabelehoeveelheidenmaximum_TA-tmgs<br/>MBH_300_toedieningssnelheid_TA-tmgs<br/>MBH_300_toedieningsduur_TA-tmgs<br/>MBH_300_zonodig_TA-tmgs<br/>MBH_300_tijdstippen_niet_flexibel_TA-tmgs<br/>MBH_300_redundantefrequentie_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7|| || MBH_300_magistraalalleingredienten<br/>MBH_300_magistraalactieveingredient<br/>MBH_300_magistraal90miljoennr<br/>MBH_300_vrijetekstproduct|| MBH_300_magistraalalleingredienten_TA<br/>MBH_300_magistraalactieveingredient_TA<br/>MBH_300_magistraal90miljoennr_TA<br/>MBH_300_vrijetekstproduct_TA | + | |7|| || MBH_300_magistraalalleingredienten-tmgs<br/>MBH_300_magistraalactieveingredient-tmgs<br/>MBH_300_magistraal90miljoennr-tmgs<br/>MBH_300_vrijetekstproduct-tmgs|| MBH_300_magistraalalleingredienten_TA-tmgs<br/>MBH_300_magistraalactieveingredient_TA-tmgs<br/>MBH_300_magistraal90miljoennr_TA-tmgs<br/>MBH_300_vrijetekstproduct_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |10|| || MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_TA | + | |10|| || MBH_300_ZINRvoorschrijven-tmgs|| MBH_300_ZINRvoorschrijven_TA-tmgs |
|} | |} | ||
<section end=overview-MGR- /> | <section end=overview-MGR- /> | ||
| Regel 178: | Regel 182: | ||
| Scenario|| Beschrijving|| MBH id|| TA id | | Scenario|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1.1|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_300_start_eind|| MBH_300_start_eind_TA | + | |1.1|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum</div>|| MBH_300_start_eind-tmgs|| MBH_300_start_eind_TA-tmgs |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |1.2a|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken)</div>|| MBH_300_start_duur-tmgs|| MBH_300_start_duur_TA-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1. | + | |1.2b|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen)</div>|| MBH_300_start_duur2-tmgs|| MBH_300_start_duur2_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1. | + | |1.3|| <div>Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie)</div>|| MBH_300_chronisch-tmgs|| MBH_300_chronisch_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1. | + | |1.4|| <div>Toedieningsafspraak met eenheid 'dosis/stuks'</div>|| MBH_300_dosis_stuks-tmgs|| MBH_300_dosis_stuks_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |1. | + | |1.6|| Toedieningsafspraak met gebruiksperiode criterium|| MBH_300_start_criterium-tmgs|| MBH_300_start_criterium_TA-tmgs |
|} | |} | ||
<section end=overview-MGR-1 /> | <section end=overview-MGR-1 /> | ||
| Regel 195: | Regel 201: | ||
| Scenario|| Beschrijving|| MBH id|| TA id | | Scenario|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.1|| Aanvullende instructie|| MBH_300_aanvullendeinstructie|| MBH_300_aanvullendeinstructie_TA | + | |2.1|| Aanvullende instructie|| MBH_300_aanvullendeinstructie-tmgs|| MBH_300_aanvullendeinstructie_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.2|| Toelichting|| MBH_300_toelichting|| MBH_300_toelichting_TA | + | |2.2|| Toelichting|| MBH_300_toelichting-tmgs|| MBH_300_toelichting_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.3|| Reden van voorschrijven|| MBH_300_redenvanvoorschrijven|| MBH_300_redenvanvoorschrijven_TA | + | |2.3|| Reden van voorschrijven|| MBH_300_redenvanvoorschrijven-tmgs|| MBH_300_redenvanvoorschrijven_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.4|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen|| MBH_300_aanvullendeinformatiewensen_TA | + | |2.4|| Aanvullende informatie|| MBH_300_aanvullendeinformatiewensen-tmgs|| MBH_300_aanvullendeinformatiewensen_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |2.5|| Toedieningsweg|| MBH_300_Toedieningsweg|| MBH_300_Toedieningsweg_TA | + | |2.5|| Toedieningsweg|| MBH_300_Toedieningsweg-tmgs|| MBH_300_Toedieningsweg_TA-tmgs |
|} | |} | ||
<section end=overview-MGR-2 /> | <section end=overview-MGR-2 /> | ||
| Regel 212: | Regel 218: | ||
| Scenario|| Beschrijving|| MBH id|| TA id | | Scenario|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.1|| <div>Stop-toedieningsafspraak, met reden staken</div>|| MBH_300_stoppen|| MBH_300_stoppen_TA_start<br/>MBH_300_stoppen_TA_staken | + | |3.1|| <div>Stop-toedieningsafspraak, met reden staken</div>|| MBH_300_stoppen-tmgs|| MBH_300_stoppen_TA_start-tmgs<br/>MBH_300_stoppen_TA_staken-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.2|| Wijziging toedieningsafspraak, met reden wijziging<br/>|| MBH_300_wijzigen_verhoging|| MBH_300_wijzigen_verhoging_TA_start<br/>MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE<br/>MBH_300_wijzigen_verhoging_TA_techstaken | + | |3.2|| Wijziging toedieningsafspraak, met reden wijziging<br/>|| MBH_300_wijzigen_verhoging-tmgs|| MBH_300_wijzigen_verhoging_TA_start-tmgs<br/>MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs<br/>MBH_300_wijzigen_verhoging_TA_techstaken-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.3|| <div>Wijziging toedieningsafspraak, met reden wijziging</div>|| MBH_300_wijzigen_verlaging|| MBH_300_wijzigen_verlaging_TA_start<br/>MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE<br/>MBH_300_wijzigen_verlaging_TA_techstaken | + | |3.3|| <div>Wijziging toedieningsafspraak, met reden wijziging</div>|| MBH_300_wijzigen_verlaging-tmgs|| MBH_300_wijzigen_verlaging_TA_start-tmgs<br/>MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs<br/>MBH_300_wijzigen_verlaging_TA_techstaken-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.4|| <div>Onderbreken toedieningsafspraak </div>|| MBH_300_onderbreken|| MBH_300_onderbreken_TA_start<br/>MBH_300_onderbreken_TA_onderbreken | + | |3.4|| <div>Onderbreken toedieningsafspraak </div>|| MBH_300_onderbreken-tmgs|| MBH_300_onderbreken_TA_start-tmgs<br/>MBH_300_onderbreken_TA_onderbreken-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.5|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Tweede MVE ivm TA met nieuwe PRK. </span></div>|| MBH_300_TAwijzigen|| MBH_300_TAwijzigen_TA_start<br/>MBH_300_TAwijzigen_TA_techstaken<br/>MBH_300_TAwijzigen_TA_anderePRK | + | |3.5|| <div><span style="color: #222222; font-family: sans-serif; font-size: 14px; background-color: #f8f9fa;">Tweede MVE ivm TA met nieuwe PRK. </span></div>|| MBH_300_TAwijzigen-tmgs|| MBH_300_TAwijzigen_TA_start-tmgs<br/>MBH_300_TAwijzigen_TA_techstaken-tmgs<br/>MBH_300_TAwijzigen_TA_anderePRK-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.6|| Annuleren toedieningsafspraak|| MBH_300_annuleren|| MBH_300_annuleren_TA_starten<br/>MBH_300_annuleren_TA_geannuleerd | + | |3.6|| Annuleren toedieningsafspraak|| MBH_300_annuleren-tmgs|| MBH_300_annuleren_TA_starten-tmgs<br/>MBH_300_annuleren_TA_geannuleerd-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.7|| Stoppen van een TA bij twee parallelle TA's|| MBH_300_stoppen_parallele_TA|| MBH_300_stoppen_parallele_TA_TA_start_GDS<br/>MBH_300_stoppen_parallele_TA_TA_start_zonodig<br/>MBH_300_stoppen_parallele_TA_TA_stop_zonodig<br/>MBH_300_stoppen_parallele_TA_TA_start2_zonodig | + | |3.7|| Stoppen van een TA bij twee parallelle TA's|| MBH_300_stoppen_parallele_TA-tmgs|| MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs<br/>MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.10|| TA waarin een correctie plaatsvindt|| MBH_300_wijzigen_correctie|| MBH_300_wijzigen_correctie_TA<br/>MBH_300_wijzigen_correctie_TA_stopTA<br/>MBH_300_wijzigen_correctie_TA_correctieTA | + | |3.10|| TA waarin een correctie plaatsvindt|| MBH_300_wijzigen_correctie-tmgs|| MBH_300_wijzigen_correctie_TA-tmgs<br/>MBH_300_wijzigen_correctie_TA_stopTA-tmgs<br/>MBH_300_wijzigen_correctie_TA_correctieTA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.11|| TA waaronder een MTD wordt opgeschort|| MBH_300_MTDopschorten|| MBH_300_MTDopschorten_TA | + | |3.11|| TA waaronder een MTD wordt opgeschort|| MBH_300_MTDopschorten-tmgs|| MBH_300_MTDopschorten_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.12|| TA waaronder een MTD een afwijkende toegediende hoeveelheid heeft|| mbh_300_AfwijkendeToediening|| mbh_300_AfwijkendeToediening_TA | + | |3.12|| TA waaronder een MTD een afwijkende toegediende hoeveelheid heeft|| mbh_300_AfwijkendeToediening-tmgs|| mbh_300_AfwijkendeToediening_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |3.13|| TA waaronder een MTD een correctie toediening heeft|| MBH_300_CorrectieToediening || MBH_300_CorrectieToediening_TA | + | |3.13|| TA waaronder een MTD een correctie toediening heeft|| MBH_300_CorrectieToediening -tmgs|| MBH_300_CorrectieToediening_TA-tmgs |
|} | |} | ||
<section end=overview-MGR-3 /> | <section end=overview-MGR-3 /> | ||
| Regel 241: | Regel 247: | ||
| Scenario|| Beschrijving|| MBH id|| TA id | | Scenario|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6.1|| Variabele frequentie|| MBH_300_variabelefrequentie|| MBH_300_variabelefrequentie_TA | + | |6.1|| Variabele frequentie|| MBH_300_variabelefrequentie-tmgs|| MBH_300_variabelefrequentie_TA-tmgs |
| + | |-style="vertical-align:top;|style="background-color: white;" | ||
| + | |6.2|| Interval|| MBH_300_interval-tmgs|| MBH_300_interval_TA-tmgs | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.3|| Variabele hoeveelheid (1)|| MBH_300_variabelehoeveelheid-tmgs|| MBH_300_variabelehoeveelheid_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.4|| Zonder keerdosis|| MBH_300_zonderkeerdosis-tmgs|| MBH_300_zonderkeerdosis_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.5|| Bijzondere keerdosis|| MBH_300_bijzonderekeerdosis-tmgs|| MBH_300_bijzonderekeerdosis_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.6|| Variabele hoeveelheid (2)|| MBH_300_variabelehoeveelheid2-tmgs|| MBH_300_variabelehoeveelheid2_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.7a|| Tijdstippen flexibel|| MBH_300_tijdstippen_flexibel-tmgs|| MBH_300_tijdstippen_flexibel_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.7b|| Tijdstippen niet flexibel|| MBH_300_tijdstippen_niet_flexibel-tmgs|| MBH_300_tijdstippen_niet_flexibel_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.8|| Weekdagen|| MBH_300_weekdagen-tmgs|| MBH_300_weekdagen_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.9|| Dagdeel|| MBH_300_dagdeel-tmgs|| MBH_300_dagdeel_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.10|| Cyclisch schema|| MBH_300_cyclischschema-tmgs|| MBH_300_cyclischschema_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.11|| Afbouw schema en doseerduur|| MBH_300_afbouwschema-tmgs|| MBH_300_afbouwschema_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.12|| Variabele hoeveelheid en maximum|| MBH_300_variabelehoeveelheidenmaximum-tmgs|| MBH_300_variabelehoeveelheidenmaximum_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.13|| Toedieningssnelheid|| MBH_300_toedieningssnelheid-tmgs|| MBH_300_toedieningssnelheid_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.14|| Toedieningsduur|| MBH_300_toedieningsduur-tmgs|| MBH_300_toedieningsduur_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.15|| Zo nodig|| MBH_300_zonodig-tmgs|| MBH_300_zonodig_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |6. | + | |6.16|| Redundante frequentie|| MBH_300_redundantefrequentie-tmgs|| MBH_300_redundantefrequentie_TA-tmgs |
|} | |} | ||
<section end=overview-MGR-6 /> | <section end=overview-MGR-6 /> | ||
| Regel 280: | Regel 288: | ||
| Scenario|| Beschrijving|| MBH id|| TA id | | Scenario|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten|| MBH_300_magistraalalleingredienten_TA | + | |7.1|| Alle ingrediënten|| MBH_300_magistraalalleingredienten-tmgs|| MBH_300_magistraalalleingredienten_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient|| MBH_300_magistraalactieveingredient_TA | + | |7.2|| Actief ingrediënt|| MBH_300_magistraalactieveingredient-tmgs|| MBH_300_magistraalactieveingredient_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr|| MBH_300_magistraal90miljoennr_TA | + | |7.3|| 90 miljoen nummer|| MBH_300_magistraal90miljoennr-tmgs|| MBH_300_magistraal90miljoennr_TA-tmgs |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |7.4|| Vrije tekst product|| MBH_300_vrijetekstproduct|| MBH_300_vrijetekstproduct_TA | + | |7.4|| Vrije tekst product|| MBH_300_vrijetekstproduct-tmgs|| MBH_300_vrijetekstproduct_TA-tmgs |
|} | |} | ||
<section end=overview-MGR-7 /> | <section end=overview-MGR-7 /> | ||
| Regel 295: | Regel 303: | ||
| Scenario|| Beschrijving|| MBH id|| TA id | | Scenario|| Beschrijving|| MBH id|| TA id | ||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
| − | |10.1|| ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven|| MBH_300_ZINRvoorschrijven_TA | + | |10.1|| ZI-nr geneesmiddel|| MBH_300_ZINRvoorschrijven-tmgs|| MBH_300_ZINRvoorschrijven_TA-tmgs |
|} | |} | ||
<section end=overview-MGR-10 /> | <section end=overview-MGR-10 /> | ||
| Regel 333: | Regel 341: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset1-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset1-v30 /> | |}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset1-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset1-v30 /> | ||
| − | ==== Scenario 1 - MBH_300_start_eind==== | + | ==== Scenario 1 - MBH_300_start_eind-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_eind_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_eind_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 343: | Regel 351: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_start_eind_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 10 dagen om 12:20 uur | |style="background-color: white;"|T - 10 dagen om 12:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 364: | Regel 372: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"|METOCLOPRAMIDE HCL | + | |style="background-color: white;"|METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 380: | Regel 388: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 388: | Regel 396: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_start_eind_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_start_eind-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 1 - MBH_300_start_duur==== | + | ==== Scenario 1 - MBH_300_start_duur-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_duur_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_duur_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 408: | Regel 416: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_start_duur_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 20 dagen om 12:30 uur | |style="background-color: white;"|T - 20 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 429: | Regel 437: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 445: | Regel 453: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 453: | Regel 461: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_start_duur_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_start_duur-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 1 - MBH_300_chronisch==== | + | ==== Scenario 1 - MBH_300_chronisch-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_chronisch_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_chronisch_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 473: | Regel 481: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_chronisch_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 30 dagen om 12:32 uur | |style="background-color: white;"|T - 30 dagen om 12:32 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 491: | Regel 499: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 507: | Regel 515: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 515: | Regel 523: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_chronisch_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 1 - MBH_300_start_duur2==== | + | ==== Scenario 1 - MBH_300_start_duur2-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_duur2_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_duur2_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 535: | Regel 543: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_start_duur2_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 60 dagen om 12:30 uur | |style="background-color: white;"|T - 60 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 556: | Regel 564: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 572: | Regel 580: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 580: | Regel 588: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_start_duur2_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_start_duur2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 1 - MBH_300_dosis_stuks==== | + | ==== Scenario 1 - MBH_300_dosis_stuks-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_dosis_stuks_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_dosis_stuks_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 600: | Regel 608: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_dosis_stuks_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 130 dagen om 12:35 uur | |style="background-color: white;"|T - 130 dagen om 12:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 621: | Regel 629: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 637: | Regel 645: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 dosis, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 645: | Regel 653: | ||
|style="background-color: white;"|2 maal per dag 1 dosis | |style="background-color: white;"|2 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_dosis_stuks_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_dosis_stuks-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Scenario 1 - MBH_300_start_criterium-tmgs==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_criterium_TA-tmgs | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_start_criterium_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 12:20 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 3 dagen (3 dagen voor operatie starten)'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T + 1 dag | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Gebruiksduur | ||
| + | |style="background-color: white;"|3 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|CHLOORHEXIDINE DIGLUCONAAT CREME 1% (code = '1189921' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag, cutaan | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 663: | Regel 736: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset1-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset1-v30 /> | |}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset1-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset1-v30 /> | ||
== TEST Medicatiegegevens TA Scenarioset 1== | == TEST Medicatiegegevens TA Scenarioset 1== | ||
| Regel 708: | Regel 784: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-1 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-1 /> | ||
| − | ==== Scenario 1.1 - MBH_300_start_eind==== | + | ==== Scenario 1.1 - MBH_300_start_eind-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_eind_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_eind_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 718: | Regel 794: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_eind_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_start_eind_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 10 dagen om 12:20 uur | |style="background-color: white;"|T - 10 dagen om 12:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 739: | Regel 815: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"|METOCLOPRAMIDE HCL | + | |style="background-color: white;"|METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 755: | Regel 831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 763: | Regel 839: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_start_eind_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_start_eind-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 781: | Regel 857: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-1 /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-1 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-1 /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-1 /> | ||
== TEST Medicatiegegevens TA Scenarioset 1== | == TEST Medicatiegegevens TA Scenarioset 1== | ||
| Regel 826: | Regel 905: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2a /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2a /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2a /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2a /> | ||
| − | ==== Scenario 1.2a - MBH_300_start_duur==== | + | ==== Scenario 1.2a - MBH_300_start_duur-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_duur_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_duur_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 836: | Regel 915: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_start_duur_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 20 dagen om 12:30 uur | |style="background-color: white;"|T - 20 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 857: | Regel 936: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 873: | Regel 952: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 881: | Regel 960: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_start_duur_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_start_duur-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 899: | Regel 978: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2a /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-2a /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2a /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-2a /> | ||
== TEST Medicatiegegevens TA Scenarioset 1== | == TEST Medicatiegegevens TA Scenarioset 1== | ||
| Regel 944: | Regel 1.026: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2b /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2b /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2b /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2b /> | ||
| − | ==== Scenario 1.2b - MBH_300_start_duur2==== | + | ==== Scenario 1.2b - MBH_300_start_duur2-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_duur2_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_duur2_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 954: | Regel 1.036: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_start_duur2_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 60 dagen om 12:30 uur | |style="background-color: white;"|T - 60 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 975: | Regel 1.057: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 991: | Regel 1.073: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 999: | Regel 1.081: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_start_duur2_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_start_duur2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.017: | Regel 1.099: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2b /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-2b /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-2b /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-2b /> | ||
== TEST Medicatiegegevens TA Scenarioset 1== | == TEST Medicatiegegevens TA Scenarioset 1== | ||
| Regel 1.062: | Regel 1.147: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-3 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-3 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-3 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-3 /> | ||
| − | ==== Scenario 1.3 - MBH_300_chronisch==== | + | ==== Scenario 1.3 - MBH_300_chronisch-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_chronisch_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_chronisch_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.072: | Regel 1.157: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_chronisch_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 30 dagen om 12:32 uur | |style="background-color: white;"|T - 30 dagen om 12:32 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.090: | Regel 1.175: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 1.106: | Regel 1.191: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 1.114: | Regel 1.199: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_chronisch_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.132: | Regel 1.217: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-3 /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-3 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-3 /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-3 /> | ||
== TEST Medicatiegegevens TA Scenarioset 1== | == TEST Medicatiegegevens TA Scenarioset 1== | ||
| Regel 1.177: | Regel 1.265: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-4 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-4 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-4 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-4 /> | ||
| − | ==== Scenario 1.4 - MBH_300_dosis_stuks==== | + | ==== Scenario 1.4 - MBH_300_dosis_stuks-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_dosis_stuks_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_dosis_stuks_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.187: | Regel 1.275: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_dosis_stuks_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_dosis_stuks_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 130 dagen om 12:35 uur | |style="background-color: white;"|T - 130 dagen om 12:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.208: | Regel 1.296: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 1.224: | Regel 1.312: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 dosis, inhalatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 1.232: | Regel 1.320: | ||
|style="background-color: white;"|2 maal per dag 1 dosis | |style="background-color: white;"|2 maal per dag 1 dosis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_dosis_stuks_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_dosis_stuks-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.250: | Regel 1.338: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-4 /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-4 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-4 /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-4 /> | ||
| − | == TEST Medicatiegegevens TA Scenarioset | + | == TEST Medicatiegegevens TA Scenarioset 1== |
| − | <section begin=mg-mp-smg-tst-TA- | + | <section begin=mg-mp-smg-tst-TA-Scenarioset1-v30-1-6 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-6 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.284: | Regel 1.375: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Brugge |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900419 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|16 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mg-mp-smg-tst-TA- | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset1-v30-1-6 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-6 /> |
| − | ==== Scenario | + | ==== Scenario 1.6 - MBH_300_start_criterium-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_start_criterium_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.305: | Regel 1.396: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 12:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 3 dagen (3 dagen voor operatie starten)'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.326: | Regel 1.417: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CHLOORHEXIDINE DIGLUCONAAT CREME 1% (code = '1189921' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_start_criterium-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.371: | Regel 1.459: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| − | |}<section end=mbhs-mg-mp-smg-tst-TA- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset1-v30-1-6 /><section end=mg-mp-smg-tst-TA-Scenarioset1-v30-1-6 /> | ||
== TEST Medicatiegegevens TA Scenarioset 2== | == TEST Medicatiegegevens TA Scenarioset 2== | ||
| − | <section begin= | + | <section begin=mg-mp-smg-tst-TA-Scenarioset2-v30-2-1 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-1 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.415: | Regel 1.506: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient- | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-1 /> |
| − | ==== Scenario 2 - MBH_300_aanvullendeinstructie==== | + | ==== Scenario 2.1 - MBH_300_aanvullendeinstructie-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_aanvullendeinstructie_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_aanvullendeinstructie_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.426: | Regel 1.517: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_aanvullendeinstructie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 4 maanden om 09:00 uur | |style="background-color: white;"|T - 4 maanden om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.447: | Regel 1.538: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 1.463: | Regel 1.554: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Bij het eten innemen, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Bij het eten innemen | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Bij het eten innemen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.474: | Regel 1.565: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== | + | ==== Bouwstenen ==== |
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="4"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="2"|OrganisatieNaam |
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
| + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-1 /><section end=mg-mp-smg-tst-TA-Scenarioset2-v30-2-1 /> | ||
| + | == TEST Medicatiegegevens TA Scenarioset 2== | ||
| + | <section begin=mgsets-mp-smg-tst-TA-Scenarioset2-v30 /><section begin=patient-mgsets-mp-smg-tst-TA-Scenarioset2-v30 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Initialen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Achternaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geboortedatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | + | |}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset2-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset2-v30 /> | |
| − | + | ==== Scenario 2 - MBH_300_aanvullendeinstructie-tmgs==== | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |- | ||
| − | |||
| − | |||
| − | |||
| − | ==== Scenario 2 - | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_aanvullendeinstructie_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.559: | Regel 1.641: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 8 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.580: | Regel 1.662: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Bij het eten innemen, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Bij het eten innemen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinstructie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 2 - | + | ==== Scenario 2 - MBH_300_toelichting-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toelichting_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.624: | Regel 1.709: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.645: | Regel 1.727: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 1.661: | Regel 1.743: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 1.667: | Regel 1.749: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toelichting | |colspan="3"|Toelichting | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|In overleg met specialist |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 2 - | + | ==== Scenario 2 - MBH_300_redenvanvoorschrijven-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_redenvanvoorschrijven_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.692: | Regel 1.774: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.713: | Regel 1.795: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== | + | ==== Scenario 2 - MBH_300_aanvullendeinformatiewensen-tmgs==== |
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_aanvullendeinformatiewensen_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Identificatie |
| + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen om 09:06 uur |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
| − | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | + | |colspan="4"|Gebruiksinstructie | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan=" | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="4"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 19:00 1 stuk - let op, exacte toedientijd(en), Oraal |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |colspan="2"|Toedieningsweg |
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|elke dag om 19:00 1 stuk - let op, exacte toedientijd(en) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toelichting | ||
| + | |style="background-color: white;"|Bijwerking besproken | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Scenario 2 - MBH_300_Toedieningsweg-tmgs==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_Toedieningsweg_TA-tmgs | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_Toedieningsweg_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 5 dagen om 09:15 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 2 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.834: | Regel 1.928: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel, In het rechter oog, oculair |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): In het rechter oog | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toelichting | |colspan="3"|Toelichting | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Gebruiksinstructie gegeven |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.879: | Regel 1.976: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| − | |}<section end=mbhs- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset2-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset2-v30 /> | ||
== TEST Medicatiegegevens TA Scenarioset 2== | == TEST Medicatiegegevens TA Scenarioset 2== | ||
| − | <section begin=mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | <section begin=mg-mp-smg-tst-TA-Scenarioset2-v30-2-2 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-2 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 1.923: | Regel 2.023: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-2 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-2 /> |
| − | ==== Scenario 2. | + | ==== Scenario 2.2 - MBH_300_toelichting-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toelichting_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 1.934: | Regel 2.034: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 1.955: | Regel 2.052: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 1.971: | Regel 2.068: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 1.977: | Regel 2.074: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toelichting | ||
| + | |style="background-color: white;"|In overleg met specialist | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toelichting-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 1.997: | Regel 2.097: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| − | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-2 /><section end=mg-mp-smg-tst-TA-Scenarioset2-v30-2-2 /> | ||
== TEST Medicatiegegevens TA Scenarioset 2== | == TEST Medicatiegegevens TA Scenarioset 2== | ||
| − | <section begin=mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | <section begin=mg-mp-smg-tst-TA-Scenarioset2-v30-2-3 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-3 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.041: | Regel 2.144: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-3 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-3 /> |
| − | ==== Scenario 2. | + | ==== Scenario 2.3 - MBH_300_redenvanvoorschrijven-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_redenvanvoorschrijven_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.052: | Regel 2.155: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.073: | Regel 2.176: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 2.089: | Regel 2.192: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 2.095: | Regel 2.198: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_redenvanvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.118: | Regel 2.218: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| − | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-3 /><section end=mg-mp-smg-tst-TA-Scenarioset2-v30-2-3 /> | ||
== TEST Medicatiegegevens TA Scenarioset 2== | == TEST Medicatiegegevens TA Scenarioset 2== | ||
| − | <section begin=mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | <section begin=mg-mp-smg-tst-TA-Scenarioset2-v30-2-4 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-4 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.162: | Regel 2.265: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-4 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-4 /> |
| − | ==== Scenario 2. | + | ==== Scenario 2.4 - MBH_300_aanvullendeinformatiewensen-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_aanvullendeinformatiewensen_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.173: | Regel 2.276: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 5 dagen om 09: | + | |style="background-color: white;"|T - 5 dagen om 09:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.194: | Regel 2.297: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 19:00 1 stuk - let op, exacte toedientijd(en), Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 19:00 1 stuk - let op, exacte toedientijd(en) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toelichting | |colspan="3"|Toelichting | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bijwerking besproken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_aanvullendeinformatiewensen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 2.242: | Regel 2.342: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| − | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == TEST Medicatiegegevens TA Scenarioset | + | |colspan="2"|Adresgegevens |
| − | <section begin=mg-mp-smg-tst-TA- | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
| + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-4 /><section end=mg-mp-smg-tst-TA-Scenarioset2-v30-2-4 /> | ||
| + | == TEST Medicatiegegevens TA Scenarioset 2== | ||
| + | <section begin=mg-mp-smg-tst-TA-Scenarioset2-v30-2-5 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-5 /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 2.263: | Regel 2.366: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 2.273: | Regel 2.376: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan | + | |rowspan="2"| |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Coenen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900420 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|17 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end=patient-mg-mp-smg-tst-TA- | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset2-v30-2-5 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-5 /> |
| − | ==== Scenario | + | ==== Scenario 2.5 - MBH_300_Toedieningsweg-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_Toedieningsweg_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.300: | Regel 2.400: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.321: | Regel 2.421: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel, In het rechter oog, oculair |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): In het rechter oog | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="4"| | + | |colspan="3"|Toelichting |
| + | |style="background-color: white;"|Gebruiksinstructie gegeven | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_Toedieningsweg-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
| + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset2-v30-2-5 /><section end=mg-mp-smg-tst-TA-Scenarioset2-v30-2-5 /> | ||
| + | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | ||
| + | <section begin=mg-mp-smg-tst-TA-Scenarioset3-v30-3-1 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-1 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Voorvoegsels |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Achternaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geboortedatum |
| + | |style="background-color: white;"|18 sep 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |- | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-1 /> |
| − | + | ==== Scenario 3.1 - MBH_300_stoppen-tmgs==== | |
| − | + | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Identificatie |
| + | |style="background-color: white;"|MBH_300_stoppen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 60 dagen om 09:00 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 220 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 220 dagen |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - generiekere code |
| + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="4"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| − | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | + | |colspan="4"|RelatieMedicatieafspraak | |
| − | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_stoppen_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_stoppen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_TA_staken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.504: | Regel 2.593: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_TA_staken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 19:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.522: | Regel 2.617: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 2.538: | Regel 2.633: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 2.546: | Regel 2.641: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_stoppen_MA_staken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieToedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="4"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="2"|OrganisatieNaam |
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek Jansen en Co |
| − | + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-1 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-1 /> | |
| − | | | + | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== |
| − | |style="background-color: white;"| | + | <section begin=mg-mp-smg-tst-TA-Scenarioset3-v30-3-2 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-2 /> |
| − | |-style=" | + | {| class="wikitable" width="85%" |
| − | |colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
| − | | | + | |-style="background-color: #1F497D;; color: white; text-align:left;" |
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="3"| |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="2"|Voorvoegsels |
| + | |style="background-color: white;"|van de | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Achternaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Identificatienummer |
| + | |style="background-color: white;"|999908881 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geboortedatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |} | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-2 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-2 /> |
| + | ==== Scenario 3.2 - MBH_300_wijzigen_verhoging-tmgs==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.631: | Regel 2.737: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T - 21 dagen | |style="background-color: white;"|T - 21 dagen | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.655: | Regel 2.755: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 2.671: | Regel 2.771: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 2 dagen om 09:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 2 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"|Zorgaanbieder | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
| − | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | | | ||
| − | | | ||
| − | | | ||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - generiekere code |
| + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |
| − | |||
| − | |||
| − | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_wijzigingmetVV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | == | + | |colspan="3"|MBH identificatie |
| − | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| + | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_techstaken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.772: | Regel 2.857: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 3 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.793: | Regel 2.881: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 2.809: | Regel 2.897: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span> |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek Jansen en Co |
| − | |-style=" | + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-2 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-2 /> |
| − | + | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | |
| − | |style="background-color: white;"| | + | <section begin=mgsets-mp-smg-tst-TA-Scenarioset3-v30 /><section begin=patient-mgsets-mp-smg-tst-TA-Scenarioset3-v30 /> |
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Voorvoegsels |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Achternaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geboortedatum |
| + | |style="background-color: white;"|18 sep 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |- | + | |}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset3-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset3-v30 /> |
| − | + | ==== Scenario 3 - MBH_300_stoppen-tmgs==== | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | ==== Scenario 3 - | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.910: | Regel 3.001: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 220 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 220 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 2.928: | Regel 3.022: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 2.944: | Regel 3.038: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 2.952: | Regel 3.046: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_TA_staken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 2.970: | Regel 3.064: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_TA_staken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 19:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |colspan="2"|Einddatum |
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.004: | Regel 3.104: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.010: | Regel 3.110: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_MA_staken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Scenario 3 - MBH_300_wijzigen_verhoging-tmgs==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.037: | Regel 3.139: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
|style="background-color: white;"|T - 21 dagen | |style="background-color: white;"|T - 21 dagen | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.061: | Regel 3.157: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 3.077: | Regel 3.173: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.112: | Regel 3.199: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.133: | Regel 3.217: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.149: | Regel 3.233: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.155: | Regel 3.239: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_wijzigingmetVV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_techstaken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.175: | Regel 3.259: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 3 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.196: | Regel 3.283: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.212: | Regel 3.299: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_MA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Scenario 3 - MBH_300_wijzigen_verlaging-tmgs==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.245: | Regel 3.334: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.259: | Regel 3.348: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 14 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.269: | Regel 3.355: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 3.285: | Regel 3.371: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.320: | Regel 3.397: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.341: | Regel 3.418: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.357: | Regel 3.434: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.363: | Regel 3.440: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_techstaken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.383: | Regel 3.460: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 1 dag om | + | |style="background-color: white;"|T - 1 dag om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.407: | Regel 3.484: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.423: | Regel 3.500: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.429: | Regel 3.506: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 3 - | + | ==== Scenario 3 - MBH_300_onderbreken-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_onderbreken_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.458: | Regel 3.535: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 09:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.479: | Regel 3.556: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.495: | Regel 3.572: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_onderbreken_TA_onderbreken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.521: | Regel 3.598: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_TA_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 19:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.545: | Regel 3.622: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.561: | Regel 3.638: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.567: | Regel 3.644: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_MA_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Scenario 3 - MBH_300_TAwijzigen-tmgs==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.594: | Regel 3.673: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 12:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Gebruiksduur | |colspan="2"|Gebruiksduur | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.615: | Regel 3.694: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"|Geneesmiddel - | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"|PANTOPRAZOL TABLET MSR | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|PANTOPRAZOL TABLET MSR | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.631: | Regel 3.710: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.637: | Regel 3.716: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="3"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | |||
| − | |||
| − | |||
| − | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_techstaken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.666: | Regel 3.736: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 12:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 51 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 51 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.687: | Regel 3.760: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.703: | Regel 3.776: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.709: | Regel 3.782: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_anderePRK-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.729: | Regel 3.809: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_anderePRK-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 50 dagen om 12:35 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 18 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 50 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.753: | Regel 3.830: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.769: | Regel 3.846: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 3 - | + | ==== Scenario 3 - MBH_300_annuleren-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_annuleren_TA_starten-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.804: | Regel 3.881: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren_TA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 14:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 7 dagen om 14:10 uur, tot en met T + 49 dagen om 14:10 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 7 dagen om 14:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 49 dagen om 14:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.825: | Regel 3.902: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.841: | Regel 3.918: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.847: | Regel 3.924: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 stuk | + | |style="background-color: white;"|1 maal per week 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren_MA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_annuleren_TA_geannuleerd-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.867: | Regel 3.944: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren_TA_geannuleerd-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 14:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 7 dagen om 14:10 uur, tot en met T + 7 dagen om 14:10 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - 14 | + | |style="background-color: white;"|T + 7 dagen om 14:10 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 7 dagen om 14:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ToedieningsafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.888: | Regel 3.968: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 3.904: | Regel 3.984: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_annuleren_MA_geannuleerd-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren_TA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_annuleren-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Scenario 3 - MBH_300_stoppen_parallele_TA-tmgs==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 3.930: | Regel 4.019: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 15 dagen om 10:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, gedurende 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 3.943: | Regel 4.032: | ||
|style="background-color: white;"|T - 14 dagen | |style="background-color: white;"|T - 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 3.954: | Regel 4.040: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 3.973: | Regel 4.056: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's ochtends, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 3.979: | Regel 4.062: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's ochtends |
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Distributievorm |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.006: | Regel 4.085: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 15 dagen om 10:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, gedurende 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Gebruiksduur | |colspan="2"|Gebruiksduur | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.027: | Regel 4.106: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"|PANTOZOL TABLET MSR | + | |style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|PANTOPRAZOL TABLET MSR | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|PANTOPRAZOL TABLET MSR | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.046: | Regel 4.122: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 1 stuk 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|Bij pijn | + | |style="background-color: white;"|Bij pijn 1 stuk 's avonds |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.081: | Regel 4.148: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 10:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 14 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T - 10 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.099: | Regel 4.172: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.115: | Regel 4.191: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 1 stuk 's avonds, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 1 stuk 's avonds |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.143: | Regel 4.224: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 10:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, gedurende 23 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Gebruiksduur | ||
| + | |style="background-color: white;"|23 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.161: | Regel 4.245: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.177: | Regel 4.264: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 2 stuks 's avonds, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 4.183: | Regel 4.270: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 2 stuks 's avonds |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 3 - | + | ==== Scenario 3 - MBH_300_MTDopschorten-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_MTDopschorten_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.205: | Regel 4.299: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_MTDopschorten_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 14:07:25 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.223: | Regel 4.317: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PROPRANOLOL HCL SANDOZ TABLET 80MG (code = '603678' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PROPRANOLOL TABLET 80MG (code = '5738' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.239: | Regel 4.333: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 09:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 4.245: | Regel 4.339: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|elke dag om 09:00 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_MTDopschorten_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_MTDopschorten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Scenario 3 - mbh_300_AfwijkendeToediening-tmgs==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak mbh_300_AfwijkendeToediening_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.265: | Regel 4.361: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 10:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.289: | Regel 4.379: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMLODIPINE PCH TABLET 5MG (ALS BESILAAT) (code = '2202182' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMLODIPINE TABLET 5MG (code = '123315' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.308: | Regel 4.395: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 11:00 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 4.314: | Regel 4.401: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 11:00 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Scenario 3 - MBH_300_wijzigen_correctie-tmgs==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.341: | Regel 4.423: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 7 dagen om | + | |style="background-color: white;"|T - 7 dagen om 10:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - 7 dagen | + | |style="background-color: white;"|T - 7 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.362: | Regel 4.441: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 4.378: | Regel 4.457: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 11 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 11 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA_stopTA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.413: | Regel 4.483: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA_stopTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 11:59 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen, tot en met T - 7 dagen om 12:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - 2 dagen | + | |style="background-color: white;"|T - 7 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T - 7 dagen om 12:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.431: | Regel 4.507: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|SYMMETREL CAPSULE 100MG (code = '19380' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMANTADINE CAPSULE 100MG (code = '485' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMANTADINE CAPSULE 100MG (code = '1341' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.447: | Regel 4.526: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 11 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 4.453: | Regel 4.532: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 11 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA_stopMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA_correctieTA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Identificatie |
| + | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA_correctieTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 7 dagen om 11:59 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen om 12:01 uur, tot en met T + 1 dag om 00:00 uur'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 7 dagen om 12:01 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 1 dag om 00:00 uur |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Verstrekker |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|SYMMETREL CAPSULE 100MG (code = '19380' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMANTADINE CAPSULE 100MG (code = '485' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMANTADINE CAPSULE 100MG (code = '1341' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="2"|Omschrijving |
| + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA_correctieMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |} |
| − | ==== Scenario 3 | + | ==== Scenario 3 - MBH_300_CorrectieToediening -tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_CorrectieToediening_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.541: | Regel 4.624: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_CorrectieToediening_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 15:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.562: | Regel 4.642: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|TRIMETHOPRIM CF TABLET 300MG (code = '1089838' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|TRIMETHOPRIM TABLET (code = '16020' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.578: | Regel 4.658: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 13:45 1 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|elke dag om 13:45 1 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_CorrectieToediening_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_CorrectieToediening -tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |rowspan="4"| |
| − | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span> |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek Jansen en Co |
| + | |}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset3-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset3-v30 /> | ||
| + | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | ||
| + | <section begin=mg-mp-smg-tst-TA-Scenarioset3-v30-3-3 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-3 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="3"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Voorvoegsels |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|van de |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="2"|Achternaam |
| + | |style="background-color: white;"|XXX_Voortman | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geboortedatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-3 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-3 /> | |
| − | + | ==== Scenario 3.3 - MBH_300_wijzigen_verlaging-tmgs==== | |
| − | + | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |- | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.674: | Regel 4.755: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 4.688: | Regel 4.769: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 14 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.698: | Regel 4.776: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 4.714: | Regel 4.792: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Identificatie |
| + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 dag om 09:10 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 14 dagen |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Verstrekker |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="2"|Omschrijving |
| + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_techstaken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 4.815: | Regel 4.881: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 09:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksperiode | |colspan="3"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Ingangsdatum | |colspan="2"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 13 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Einddatum | |colspan="2"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 2 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Verstrekker | |colspan="4"|Verstrekker | ||
| Regel 4.836: | Regel 4.905: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.852: | Regel 4.921: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_MA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| + | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span> |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek Jansen en Co |
| − | | | + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-3 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-3 /> |
| − | + | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | |
| − | |style="background-color: white;"| | + | <section begin=mg-mp-smg-tst-TA-Scenarioset3-v30-3-4 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-4 /> |
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"|Geneesmiddel - generiekere code | + | |rowspan="3"| |
| − | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van de | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Voortman | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999908881 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|18 sep 1963 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-4 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-4 /> | ||
| + | ==== Scenario 3.4 - MBH_300_onderbreken-tmgs==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_onderbreken_TA_start-tmgs | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbreken_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 5 dagen om 09:06 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 4 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T + 5 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|FENETICILLINE 500MG | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 4.918: | Regel 5.062: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|3 maal per dag 1 stuk | |style="background-color: white;"|3 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbreken_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_onderbreken_TA_onderbreken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbreken_TA_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 1 dag om 19:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"|Zorgaanbieder | + | |colspan="2"|Ingangsdatum |
| + | |style="background-color: white;"|T - 4 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Einddatum | ||
| + | |style="background-color: white;"|T - 1 dag | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|3 maal per dag 1 stuk, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|3 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbreken_MA_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbreken_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|99901111 (in identificerend systeem: URA) | |style="background-color: white;"|99901111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek Jansen en Co | |style="background-color: white;"|Apotheek Jansen en Co | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-4 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-4 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-4 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-4 /> | ||
| Regel 4.984: | Regel 5.197: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 4.995: | Regel 5.208: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-5 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-5 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-5 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-5 /> | ||
| − | ==== Scenario 3.5 - MBH_300_TAwijzigen==== | + | ==== Scenario 3.5 - MBH_300_TAwijzigen-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_start | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_start-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.019: | Regel 5.232: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 60 dagen om 12:30 uur | |style="background-color: white;"|T - 60 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.040: | Regel 5.253: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.056: | Regel 5.269: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.064: | Regel 5.277: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_techstaken | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_techstaken-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.082: | Regel 5.295: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 50 dagen om 12:30 uur | |style="background-color: white;"|T - 50 dagen om 12:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.098: | Regel 5.311: | ||
|style="background-color: white;"|T - 51 dagen | |style="background-color: white;"|T - 51 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakStopType |
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.106: | Regel 5.319: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.122: | Regel 5.335: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.130: | Regel 5.343: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_anderePRK | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_TAwijzigen_TA_anderePRK-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.155: | Regel 5.368: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_TA_anderePRK (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_anderePRK-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 50 dagen om 12:35 uur | |style="background-color: white;"|T - 50 dagen om 12:35 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.176: | Regel 5.389: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken |
|style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.192: | Regel 5.405: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.200: | Regel 5.413: | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 5.225: | Regel 5.438: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-5 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-5 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-5 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-5 /> | ||
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | ||
| Regel 5.248: | Regel 5.464: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 5.259: | Regel 5.475: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-6 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-6 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-6 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-6 /> | ||
| − | ==== Scenario 3.6 - MBH_300_annuleren==== | + | ==== Scenario 3.6 - MBH_300_annuleren-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_annuleren_TA_starten | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_annuleren_TA_starten-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.283: | Regel 5.499: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_annuleren_TA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_annuleren_TA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 14:10 uur | |style="background-color: white;"|T - 2 dagen om 14:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.304: | Regel 5.520: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.320: | Regel 5.536: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.328: | Regel 5.544: | ||
|style="background-color: white;"|1 maal per week 1 stuk | |style="background-color: white;"|1 maal per week 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_annuleren_MA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_annuleren_MA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_annuleren-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_annuleren_TA_geannuleerd | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_annuleren_TA_geannuleerd-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.346: | Regel 5.562: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_annuleren_TA_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_annuleren_TA_geannuleerd-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 14:10 uur | |style="background-color: white;"|T - 1 dag om 14:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.362: | Regel 5.578: | ||
|style="background-color: white;"|T + 7 dagen om 14:10 uur | |style="background-color: white;"|T + 7 dagen om 14:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakStopType |
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.370: | Regel 5.586: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.386: | Regel 5.602: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.394: | Regel 5.610: | ||
|style="background-color: white;"|1 maal per week 1 stuk | |style="background-color: white;"|1 maal per week 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_annuleren_MA_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_annuleren_MA_geannuleerd-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_annuleren_TA_starten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_annuleren_TA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_annuleren-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 5.419: | Regel 5.635: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-6 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-6 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-6 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-6 /> | ||
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | ||
| Regel 5.442: | Regel 5.661: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 5.453: | Regel 5.672: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-7 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-7 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-7 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-7 /> | ||
| − | ==== Scenario 3.7 - MBH_300_stoppen_parallele_TA==== | + | ==== Scenario 3.7 - MBH_300_stoppen_parallele_TA-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_GDS | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.477: | Regel 5.696: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_GDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 15 dagen om 10:15 uur | |style="background-color: white;"|T - 15 dagen om 10:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.498: | Regel 5.717: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.514: | Regel 5.733: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's ochtends, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.521: | Regel 5.740: | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
|style="background-color: white;"|1 stuk 's ochtends | |style="background-color: white;"|1 stuk 's ochtends | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Distributievorm | ||
| + | |style="background-color: white;"|GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_zonodig | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.540: | Regel 5.762: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 15 dagen om 10:15 uur | |style="background-color: white;"|T - 15 dagen om 10:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.561: | Regel 5.783: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.577: | Regel 5.799: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 1 stuk 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.585: | Regel 5.807: | ||
|style="background-color: white;"|Bij pijn 1 stuk 's avonds | |style="background-color: white;"|Bij pijn 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_stop_zonodig | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.603: | Regel 5.825: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_stop_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 10 dagen om 10:05 uur | |style="background-color: white;"|T - 10 dagen om 10:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.619: | Regel 5.841: | ||
|style="background-color: white;"|T - 10 dagen | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakStopType |
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.627: | Regel 5.849: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken |
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.646: | Regel 5.868: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 1 stuk 's avonds, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.654: | Regel 5.876: | ||
|style="background-color: white;"|Bij pijn 1 stuk 's avonds | |style="background-color: white;"|Bij pijn 1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start2_zonodig | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.679: | Regel 5.901: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start2_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 10 dagen om 10:05 uur | |style="background-color: white;"|T - 10 dagen om 10:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.700: | Regel 5.922: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken |
|style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.719: | Regel 5.941: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij pijn 2 stuks 's avonds, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.727: | Regel 5.949: | ||
|style="background-color: white;"|Bij pijn 2 stuks 's avonds | |style="background-color: white;"|Bij pijn 2 stuks 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_stoppen_parallele_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 5.752: | Regel 5.974: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-7 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-7 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-7 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-7 /> | ||
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | ||
| Regel 5.775: | Regel 6.000: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 5.786: | Regel 6.011: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-10 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-10 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-10 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-10 /> | ||
| − | ==== Scenario 3.10 - MBH_300_wijzigen_correctie==== | + | ==== Scenario 3.10 - MBH_300_wijzigen_correctie-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.810: | Regel 6.035: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 7 dagen om 10:45 uur | |style="background-color: white;"|T - 7 dagen om 10:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.828: | Regel 6.053: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.844: | Regel 6.069: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 11 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.852: | Regel 6.077: | ||
|style="background-color: white;"|1 maal per dag 11 stuks | |style="background-color: white;"|1 maal per dag 11 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA_stopTA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA_stopTA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.870: | Regel 6.095: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA_stopTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA_stopTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 7 dagen om 11:59 uur | |style="background-color: white;"|T - 7 dagen om 11:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.886: | Regel 6.111: | ||
|style="background-color: white;"|T - 7 dagen om 12:00 uur | |style="background-color: white;"|T - 7 dagen om 12:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakStopType |
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.894: | Regel 6.119: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ToedieningsafspraakRedenWijzigenOfStaken |
|style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.913: | Regel 6.138: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 11 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.921: | Regel 6.146: | ||
|style="background-color: white;"|1 maal per dag 11 stuks | |style="background-color: white;"|1 maal per dag 11 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA_stopMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA_correctieTA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_wijzigen_correctie_TA_correctieTA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 5.946: | Regel 6.171: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA_correctieTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_TA_correctieTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 7 dagen om 11:59 uur | |style="background-color: white;"|T - 7 dagen om 11:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.967: | Regel 6.192: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 5.983: | Regel 6.208: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 5.991: | Regel 6.216: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA_correctieMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005 | + | |style="background-color: white;"|MBH_300_wijzigen_correctie_MA_correctieMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_wijzigen_correctie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.016: | Regel 6.234: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-10 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-10 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-10 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-10 /> | ||
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | ||
| Regel 6.039: | Regel 6.260: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 6.050: | Regel 6.271: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-11 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-11 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-11 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-11 /> | ||
| − | ==== Scenario 3.11 - MBH_300_MTDopschorten==== | + | ==== Scenario 3.11 - MBH_300_MTDopschorten-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_MTDopschorten_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_MTDopschorten_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.074: | Regel 6.295: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_MTDopschorten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_MTDopschorten_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 5 dagen om 14:07:25 uur | |style="background-color: white;"|T - 5 dagen om 14:07:25 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.092: | Regel 6.313: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 6.108: | Regel 6.329: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 09:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 6.116: | Regel 6.337: | ||
|style="background-color: white;"|elke dag om 09:00 1 stuk | |style="background-color: white;"|elke dag om 09:00 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_MTDopschorten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_MTDopschorten_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_MTDopschorten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_MTDopschorten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.134: | Regel 6.355: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-11 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-11 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-11 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-11 /> | ||
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | ||
| Regel 6.157: | Regel 6.381: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 6.168: | Regel 6.392: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-12 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-12 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-12 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-12 /> | ||
| − | ==== Scenario 3.12 - mbh_300_AfwijkendeToediening==== | + | ==== Scenario 3.12 - mbh_300_AfwijkendeToediening-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak mbh_300_AfwijkendeToediening_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak mbh_300_AfwijkendeToediening_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.192: | Regel 6.416: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|mbh_300_AfwijkendeToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 10:00 uur | |style="background-color: white;"|T - 1 dag om 10:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.210: | Regel 6.434: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 6.226: | Regel 6.450: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 11:00 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 6.234: | Regel 6.458: | ||
|style="background-color: white;"|elke dag om 11:00 2 stuks | |style="background-color: white;"|elke dag om 11:00 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|mbh_300_AfwijkendeToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|mbh_300_AfwijkendeToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|mbh_300_AfwijkendeToediening-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.252: | Regel 6.476: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-12 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-12 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-12 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-12 /> | ||
== TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | == TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)== | ||
| Regel 6.275: | Regel 6.502: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Voornamen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|C |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 6.286: | Regel 6.513: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|de | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Voortman |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999908881 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-13 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-13 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset3-v30-3-13 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-13 /> | ||
| − | ==== Scenario 3.13 - MBH_300_CorrectieToediening ==== | + | ==== Scenario 3.13 - MBH_300_CorrectieToediening -tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_CorrectieToediening_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_CorrectieToediening_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.310: | Regel 6.537: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieToediening_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_CorrectieToediening_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 15:30 uur | |style="background-color: white;"|T - 2 dagen om 15:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.328: | Regel 6.555: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 6.344: | Regel 6.571: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 13:45 1 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 6.352: | Regel 6.579: | ||
|style="background-color: white;"|elke dag om 13:45 1 stuks | |style="background-color: white;"|elke dag om 13:45 1 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieToediening_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_CorrectieToediening_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_CorrectieToediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_CorrectieToediening -tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.370: | Regel 6.597: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|99901111 (in identificerend systeem: URA) | |style="background-color: white;"|99901111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek Jansen en Co | |style="background-color: white;"|Apotheek Jansen en Co | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-13 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-13 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset3-v30-3-13 /><section end=mg-mp-smg-tst-TA-Scenarioset3-v30-3-13 /> | ||
| Regel 6.415: | Regel 6.642: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-1 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-1 /> | ||
| − | ==== Scenario 6.1 - MBH_300_variabelefrequentie==== | + | ==== Scenario 6.1 - MBH_300_variabelefrequentie-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelefrequentie_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelefrequentie_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.425: | Regel 6.652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_variabelefrequentie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:00 uur | |style="background-color: white;"|T om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.446: | Regel 6.673: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 6.462: | Regel 6.689: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 6.470: | Regel 6.697: | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_variabelefrequentie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_variabelefrequentie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.488: | Regel 6.715: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-1 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-1 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-1 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-1 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 6.533: | Regel 6.763: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-2 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-2 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-2 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-2 /> | ||
| − | ==== Scenario 6.2 - MBH_300_interval==== | + | ==== Scenario 6.2 - MBH_300_interval-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_interval_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_interval_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.543: | Regel 6.773: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_interval_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_interval_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:04 uur | |style="background-color: white;"|T om 09:04 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.561: | Regel 6.791: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 6.577: | Regel 6.807: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 6.585: | Regel 6.815: | ||
|style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden | |style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_interval_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_interval-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.603: | Regel 6.833: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-2 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-2 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-2 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-2 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 6.648: | Regel 6.881: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-3 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-3 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-3 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-3 /> | ||
| − | ==== Scenario 6.3 - MBH_300_variabelehoeveelheid==== | + | ==== Scenario 6.3 - MBH_300_variabelehoeveelheid-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.658: | Regel 6.891: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:10 uur | |style="background-color: white;"|T om 09:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.679: | Regel 6.912: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 6.695: | Regel 6.928: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 6.703: | Regel 6.936: | ||
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.721: | Regel 6.954: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-3 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-3 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-3 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-3 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 6.766: | Regel 7.002: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-4 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-4 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-4 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-4 /> | ||
| − | ==== Scenario 6.4 - MBH_300_zonderkeerdosis==== | + | ==== Scenario 6.4 - MBH_300_zonderkeerdosis-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_zonderkeerdosis_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_zonderkeerdosis_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.776: | Regel 7.012: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonderkeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_zonderkeerdosis_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:12 uur | |style="background-color: white;"|T om 09:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.797: | Regel 7.033: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 6.803: | Regel 7.039: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = ' | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = ' | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 6.813: | Regel 7.049: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.824: | Regel 7.060: | ||
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_zonderkeerdosis_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_zonderkeerdosis-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.842: | Regel 7.078: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-4 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-4 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-4 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-4 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 6.887: | Regel 7.126: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-5 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-5 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-5 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-5 /> | ||
| − | ==== Scenario 6.5 - MBH_300_bijzonderekeerdosis==== | + | ==== Scenario 6.5 - MBH_300_bijzonderekeerdosis-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_bijzonderekeerdosis_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_bijzonderekeerdosis_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 6.897: | Regel 7.136: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:15 uur | |style="background-color: white;"|T om 09:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.918: | Regel 7.157: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 6.934: | Regel 7.173: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.5 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 6.942: | Regel 7.181: | ||
|style="background-color: white;"|2 maal per dag 0.5 stuk | |style="background-color: white;"|2 maal per dag 0.5 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 6.960: | Regel 7.199: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-5 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-5 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-5 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-5 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 7.005: | Regel 7.247: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset6-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset6-v30 /> | |}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset6-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset6-v30 /> | ||
| − | ==== Scenario 6 - MBH_300_variabelefrequentie==== | + | ==== Scenario 6 - MBH_300_variabelefrequentie-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelefrequentie_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelefrequentie_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.015: | Regel 7.257: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelefrequentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_variabelefrequentie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:00 uur | |style="background-color: white;"|T om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.036: | Regel 7.278: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.052: | Regel 7.294: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.060: | Regel 7.302: | ||
|style="background-color: white;"|1 à 2 maal per dag 1 stuk | |style="background-color: white;"|1 à 2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_variabelefrequentie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_variabelefrequentie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_interval==== | + | ==== Scenario 6 - MBH_300_interval-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_interval_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_interval_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.080: | Regel 7.322: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_interval_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_interval_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:04 uur | |style="background-color: white;"|T om 09:04 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.098: | Regel 7.340: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.114: | Regel 7.356: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.122: | Regel 7.364: | ||
|style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden | |style="background-color: white;"|iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_interval_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_interval-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_variabelehoeveelheid==== | + | ==== Scenario 6 - MBH_300_variabelehoeveelheid-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.142: | Regel 7.384: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:10 uur | |style="background-color: white;"|T om 09:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.163: | Regel 7.405: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.179: | Regel 7.421: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.187: | Regel 7.429: | ||
|style="background-color: white;"|3 maal per dag 1 à 2 stuks | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_zonderkeerdosis==== | + | ==== Scenario 6 - MBH_300_zonderkeerdosis-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_zonderkeerdosis_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_zonderkeerdosis_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.207: | Regel 7.449: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonderkeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_zonderkeerdosis_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:12 uur | |style="background-color: white;"|T om 09:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.228: | Regel 7.470: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.234: | Regel 7.476: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = ' | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = ' | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 7.244: | Regel 7.486: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.255: | Regel 7.497: | ||
|style="background-color: white;"|3 maal per dag | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_zonderkeerdosis_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_zonderkeerdosis-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_bijzonderekeerdosis==== | + | ==== Scenario 6 - MBH_300_bijzonderekeerdosis-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_bijzonderekeerdosis_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_bijzonderekeerdosis_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.275: | Regel 7.517: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:15 uur | |style="background-color: white;"|T om 09:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.296: | Regel 7.538: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.312: | Regel 7.554: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.5 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.320: | Regel 7.562: | ||
|style="background-color: white;"|2 maal per dag 0.5 stuk | |style="background-color: white;"|2 maal per dag 0.5 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_bijzonderekeerdosis-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_variabelehoeveelheid2==== | + | ==== Scenario 6 - MBH_300_variabelehoeveelheid2-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid2_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid2_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.340: | Regel 7.582: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:18 uur | |style="background-color: white;"|T om 09:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.361: | Regel 7.603: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.377: | Regel 7.619: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.391: | Regel 7.633: | ||
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_tijdstippen_flexibel==== | + | ==== Scenario 6 - MBH_300_tijdstippen_flexibel-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_flexibel_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_flexibel_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.411: | Regel 7.653: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:24 uur | |style="background-color: white;"|T om 09:24 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.432: | Regel 7.674: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.448: | Regel 7.690: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.456: | Regel 7.698: | ||
|style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_weekdagen==== | + | ==== Scenario 6 - MBH_300_weekdagen-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_weekdagen_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_weekdagen_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.476: | Regel 7.718: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_weekdagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_weekdagen_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:25 uur | |style="background-color: white;"|T om 09:25 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.497: | Regel 7.739: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.513: | Regel 7.755: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.527: | Regel 7.769: | ||
|style="background-color: white;"|op maandag, woensdag en vrijdag | |style="background-color: white;"|op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_weekdagen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_weekdagen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_dagdeel==== | + | ==== Scenario 6 - MBH_300_dagdeel-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_dagdeel_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_dagdeel_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.547: | Regel 7.789: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_dagdeel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_dagdeel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:27 uur | |style="background-color: white;"|T om 09:27 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.565: | Regel 7.807: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.581: | Regel 7.823: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.589: | Regel 7.831: | ||
|style="background-color: white;"|1 stuk 's avonds | |style="background-color: white;"|1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_dagdeel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_dagdeel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_cyclischschema==== | + | ==== Scenario 6 - MBH_300_cyclischschema-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_cyclischschema_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_cyclischschema_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.609: | Regel 7.851: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_cyclischschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_cyclischschema_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:33 uur | |style="background-color: white;"|T om 09:33 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.627: | Regel 7.869: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 7.640: | Regel 7.885: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.648: | Regel 7.893: | ||
|style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|HerhaalperiodeCyclischSchema |
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_cyclischschema_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_cyclischschema-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_afbouwschema==== | + | ==== Scenario 6 - MBH_300_afbouwschema-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_afbouwschema_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_afbouwschema_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.671: | Regel 7.916: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_afbouwschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_afbouwschema_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:40 uur | |style="background-color: white;"|T om 09:40 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.692: | Regel 7.937: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.708: | Regel 7.953: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.722: | Regel 7.967: | ||
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_afbouwschema_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_afbouwschema-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_variabelehoeveelheidenmaximum==== | + | ==== Scenario 6 - MBH_300_variabelehoeveelheidenmaximum-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheidenmaximum_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheidenmaximum_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.742: | Regel 7.987: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:45 uur | |style="background-color: white;"|T om 09:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.763: | Regel 8.008: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.779: | Regel 8.024: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.787: | Regel 8.032: | ||
|style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_toedieningssnelheid==== | + | ==== Scenario 6 - MBH_300_toedieningssnelheid-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toedieningssnelheid_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toedieningssnelheid_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.807: | Regel 8.052: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_toedieningssnelheid_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:47 uur | |style="background-color: white;"|T om 09:47 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.828: | Regel 8.073: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.844: | Regel 8.089: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h, Intraveneus |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.852: | Regel 8.097: | ||
|style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h | |style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_toedieningssnelheid_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toedieningssnelheid-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_toedieningsduur==== | + | ==== Scenario 6 - MBH_300_toedieningsduur-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toedieningsduur_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toedieningsduur_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.872: | Regel 8.117: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_toedieningsduur_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:49 uur | |style="background-color: white;"|T om 09:49 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.890: | Regel 8.135: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.906: | Regel 8.151: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur, transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.914: | Regel 8.159: | ||
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_toedieningsduur_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toedieningsduur-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_zonodig==== | + | ==== Scenario 6 - MBH_300_zonodig-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_zonodig_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_zonodig_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.934: | Regel 8.179: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonodig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_zonodig_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:57 uur | |style="background-color: white;"|T om 09:57 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.955: | Regel 8.200: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 7.961: | Regel 8.206: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 7.971: | Regel 8.216: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 7.979: | Regel 8.224: | ||
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_zonodig_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 6 - MBH_300_tijdstippen_niet_flexibel==== | + | ==== Scenario 6 - MBH_300_tijdstippen_niet_flexibel-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_niet_flexibel_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_niet_flexibel_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 7.999: | Regel 8.244: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 10:15 uur | |style="background-color: white;"|T om 10:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.020: | Regel 8.265: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.033: | Regel 8.281: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en), oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 8.039: | Regel 8.287: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== | + | ==== Scenario 6 - MBH_300_redundantefrequentie-tmgs==== |
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_redundantefrequentie_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_redundantefrequentie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 09:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T om 09:45 uur, gedurende 14 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T om 09:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|14 dagen |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Verstrekker |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|PREDNISON AURO TABLET 5MG (code = '2033682' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"|G | + | |style="background-color: white;"|PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag om 10:00 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geboortedatum | + | |colspan="2"|Doseerinstructie |
| − | |style="background-color: white;"|2 nov 1963 | + | |style="background-color: white;"|1 maal per dag om 10:00 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_redundantefrequentie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_redundantefrequentie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset6-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset6-v30 /> | ||
| + | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| + | <section begin=mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|G. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Hemsbergen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900602 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|2 nov 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /> | ||
| − | ==== Scenario 6.6 - MBH_300_variabelehoeveelheid2==== | + | ==== Scenario 6.6 - MBH_300_variabelehoeveelheid2-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid2_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheid2_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.114: | Regel 8.430: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:18 uur | |style="background-color: white;"|T om 09:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.135: | Regel 8.451: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 8.151: | Regel 8.467: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.165: | Regel 8.481: | ||
|style="background-color: white;"|2 maal per dag 10 à 15 ml | |style="background-color: white;"|2 maal per dag 10 à 15 ml | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheid2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.183: | Regel 8.499: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-6 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 8.228: | Regel 8.547: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7a /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7a /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7a /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7a /> | ||
| − | ==== Scenario 6.7a - MBH_300_tijdstippen_flexibel==== | + | ==== Scenario 6.7a - MBH_300_tijdstippen_flexibel-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_flexibel_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_flexibel_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.238: | Regel 8.557: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:24 uur | |style="background-color: white;"|T om 09:24 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.259: | Regel 8.578: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 8.275: | Regel 8.594: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 8.283: | Regel 8.602: | ||
|style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_flexibel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.301: | Regel 8.620: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7a /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-7a /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7a /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-7a /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 8.346: | Regel 8.668: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7b /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7b /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7b /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7b /> | ||
| − | ==== Scenario 6.7b - MBH_300_tijdstippen_niet_flexibel==== | + | ==== Scenario 6.7b - MBH_300_tijdstippen_niet_flexibel-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_niet_flexibel_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_tijdstippen_niet_flexibel_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.356: | Regel 8.678: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 10:15 uur | |style="background-color: white;"|T om 10:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.377: | Regel 8.699: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.390: | Regel 8.715: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en), oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 8.396: | Regel 8.721: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Doseerinstructie | |colspan="2"|Doseerinstructie | ||
| − | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_tijdstippen_niet_flexibel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.416: | Regel 8.741: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7b /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-7b /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-7b /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-7b /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 8.461: | Regel 8.789: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-8 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-8 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-8 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-8 /> | ||
| − | ==== Scenario 6.8 - MBH_300_weekdagen==== | + | ==== Scenario 6.8 - MBH_300_weekdagen-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_weekdagen_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_weekdagen_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.471: | Regel 8.799: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_weekdagen_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_weekdagen_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:25 uur | |style="background-color: white;"|T om 09:25 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.492: | Regel 8.820: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 8.508: | Regel 8.836: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
|style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|AanvullendeInstructie |
|style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.522: | Regel 8.850: | ||
|style="background-color: white;"|op maandag, woensdag en vrijdag | |style="background-color: white;"|op maandag, woensdag en vrijdag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_weekdagen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_weekdagen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.540: | Regel 8.868: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-8 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-8 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-8 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-8 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 8.585: | Regel 8.916: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-9 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-9 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-9 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-9 /> | ||
| − | ==== Scenario 6.9 - MBH_300_dagdeel==== | + | ==== Scenario 6.9 - MBH_300_dagdeel-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_dagdeel_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_dagdeel_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.595: | Regel 8.926: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_dagdeel_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_dagdeel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:27 uur | |style="background-color: white;"|T om 09:27 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.613: | Regel 8.944: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 8.629: | Regel 8.960: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 8.637: | Regel 8.968: | ||
|style="background-color: white;"|1 stuk 's avonds | |style="background-color: white;"|1 stuk 's avonds | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_dagdeel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_dagdeel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.655: | Regel 8.986: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-9 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-9 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-9 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-9 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 8.700: | Regel 9.034: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-10 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-10 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-10 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-10 /> | ||
| − | ==== Scenario 6.10 - MBH_300_cyclischschema==== | + | ==== Scenario 6.10 - MBH_300_cyclischschema-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_cyclischschema_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_cyclischschema_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.710: | Regel 9.044: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_cyclischschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_cyclischschema_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:33 uur | |style="background-color: white;"|T om 09:33 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.728: | Regel 9.062: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksinstructie | |colspan="4"|Gebruiksinstructie | ||
| Regel 8.741: | Regel 9.078: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 8.749: | Regel 9.086: | ||
|style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|HerhaalperiodeCyclischSchema |
|style="background-color: white;"|28 dagen | |style="background-color: white;"|28 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_cyclischschema_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_cyclischschema-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.770: | Regel 9.107: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-10 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-10 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-10 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-10 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 8.815: | Regel 9.155: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-11 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-11 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-11 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-11 /> | ||
| − | ==== Scenario 6.11 - MBH_300_afbouwschema==== | + | ==== Scenario 6.11 - MBH_300_afbouwschema-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_afbouwschema_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_afbouwschema_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.825: | Regel 9.165: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_afbouwschema_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_afbouwschema_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:40 uur | |style="background-color: white;"|T om 09:40 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.846: | Regel 9.186: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 8.862: | Regel 9.202: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 8.876: | Regel 9.216: | ||
|style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_afbouwschema_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_afbouwschema-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 8.894: | Regel 9.234: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-11 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-11 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-11 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-11 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 8.939: | Regel 9.282: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-12 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-12 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-12 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-12 /> | ||
| − | ==== Scenario 6.12 - MBH_300_variabelehoeveelheidenmaximum==== | + | ==== Scenario 6.12 - MBH_300_variabelehoeveelheidenmaximum-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheidenmaximum_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_variabelehoeveelheidenmaximum_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 8.949: | Regel 9.292: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:45 uur | |style="background-color: white;"|T om 09:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.970: | Regel 9.313: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 8.986: | Regel 9.329: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 8.994: | Regel 9.337: | ||
|style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_variabelehoeveelheidenmaximum-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.012: | Regel 9.355: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-12 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-12 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-12 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-12 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 9.057: | Regel 9.403: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-13 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-13 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-13 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-13 /> | ||
| − | ==== Scenario 6.13 - MBH_300_toedieningssnelheid==== | + | ==== Scenario 6.13 - MBH_300_toedieningssnelheid-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toedieningssnelheid_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toedieningssnelheid_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.067: | Regel 9.413: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningssnelheid_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_toedieningssnelheid_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:47 uur | |style="background-color: white;"|T om 09:47 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.088: | Regel 9.434: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 9.104: | Regel 9.450: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h, Intraveneus |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 9.112: | Regel 9.458: | ||
|style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h | |style="background-color: white;"|toedieningssnelheid: 0.2 à 0.5 ml/h | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_toedieningssnelheid_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toedieningssnelheid-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.130: | Regel 9.476: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-13 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-13 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-13 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-13 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 9.175: | Regel 9.524: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-14 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-14 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-14 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-14 /> | ||
| − | ==== Scenario 6.14 - MBH_300_toedieningsduur==== | + | ==== Scenario 6.14 - MBH_300_toedieningsduur-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toedieningsduur_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_toedieningsduur_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.185: | Regel 9.534: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningsduur_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_toedieningsduur_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:49 uur | |style="background-color: white;"|T om 09:49 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.203: | Regel 9.552: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 9.219: | Regel 9.568: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur, transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 9.227: | Regel 9.576: | ||
|style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_toedieningsduur_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_toedieningsduur-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.245: | Regel 9.594: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-14 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-14 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-14 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-14 /> | ||
== TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== | ||
| Regel 9.290: | Regel 9.642: | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-15 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-15 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-15 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-15 /> | ||
| − | ==== Scenario 6.15 - MBH_300_zonodig==== | + | ==== Scenario 6.15 - MBH_300_zonodig-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_zonodig_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_zonodig_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.300: | Regel 9.652: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonodig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_zonodig_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 09:57 uur | |style="background-color: white;"|T om 09:57 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.321: | Regel 9.673: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| Regel 9.327: | Regel 9.679: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 9.337: | Regel 9.689: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 9.345: | Regel 9.697: | ||
|style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_zonodig_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.363: | Regel 9.715: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
| − | |style="background-color: white;"|Apotheek | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-15 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-15 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-15 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-15 /> | ||
| − | == TEST Medicatiegegevens TA Scenarioset | + | == TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)== |
| − | <section begin=mg-mp-smg-tst-TA- | + | <section begin=mg-mp-smg-tst-TA-Scenarioset6-v30-6-16 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-16 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 9.397: | Regel 9.752: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hemsbergen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999900602 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 nov 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end=patient-mg-mp-smg-tst-TA- | + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset6-v30-6-16 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-16 /> |
| − | ==== Scenario | + | ==== Scenario 6.16 - MBH_300_redundantefrequentie-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_redundantefrequentie_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| − | |colspan="4" width="25%"| Gegevenselement | + | |colspan="3" width="25%"| Gegevenselement |
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_redundantefrequentie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 09:45 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T om 09:45 uur, gedurende 14 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Ingangsdatum | ||
| + | |style="background-color: white;"|T om 09:45 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Gebruiksduur | ||
| + | |style="background-color: white;"|14 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|PREDNISON AURO TABLET 5MG (code = '2033682' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag om 10:00 1 stuk, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag om 10:00 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_redundantefrequentie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_redundantefrequentie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | ==== Bouwstenen ==== | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="3" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset6-v30-6-16 /><section end=mg-mp-smg-tst-TA-Scenarioset6-v30-6-16 /> | ||
| + | == TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | ||
| + | <section begin=mg-mp-smg-tst-TA-Scenarioset7-v30-7-1 /><section begin=patient-mg-mp-smg-tst-TA-Scenarioset7-v30-7-1 /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|G. | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Hess | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999900614 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|3 nov 1963 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset7-v30-7-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-1 /> | ||
| + | ==== Scenario 7.1 - MBH_300_magistraalalleingredienten-tmgs==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraalalleingredienten_TA-tmgs | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.439: | Regel 9.915: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="11"| | |rowspan="11"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.455: | Regel 9.931: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.465: | Regel 9.941: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.476: | Regel 9.952: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 9.484: | Regel 9.960: | ||
|style="background-color: white;"|Zo nodig | |style="background-color: white;"|Zo nodig | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.502: | Regel 9.978: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-1 /><section end=mg-mp-smg-tst-TA-Scenarioset7-v30-7-1 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-1 /><section end=mg-mp-smg-tst-TA-Scenarioset7-v30-7-1 /> | ||
== TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | ||
| Regel 9.547: | Regel 10.026: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset7-v30-7-2 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-2 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset7-v30-7-2 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-2 /> | ||
| − | ==== Scenario 7.2 - MBH_300_magistraalactieveingredient==== | + | ==== Scenario 7.2 - MBH_300_magistraalactieveingredient-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraalactieveingredient_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraalactieveingredient_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 9.557: | Regel 10.036: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:05 uur | |style="background-color: white;"|T om 13:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.578: | Regel 10.057: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.594: | Regel 10.073: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.605: | Regel 10.084: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 9.613: | Regel 10.092: | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.631: | Regel 10.110: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-2 /><section end=mg-mp-smg-tst-TA-Scenarioset7-v30-7-2 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-2 /><section end=mg-mp-smg-tst-TA-Scenarioset7-v30-7-2 /> | ||
== TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | ||
| Regel 9.676: | Regel 10.158: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset7-v30-7-3 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-3 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset7-v30-7-3 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-3 /> | ||
| − | ==== Scenario 7.3 - MBH_300_magistraal90miljoennr==== | + | ==== Scenario 7.3 - MBH_300_magistraal90miljoennr-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraal90miljoennr_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraal90miljoennr_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 9.686: | Regel 10.168: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:08 uur | |style="background-color: white;"|T om 13:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.707: | Regel 10.189: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="8"| | |rowspan="8"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductCode |
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.726: | Regel 10.208: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.737: | Regel 10.219: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 9.745: | Regel 10.227: | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.763: | Regel 10.245: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-3 /><section end=mg-mp-smg-tst-TA-Scenarioset7-v30-7-3 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-3 /><section end=mg-mp-smg-tst-TA-Scenarioset7-v30-7-3 /> | ||
== TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | ||
| Regel 9.808: | Regel 10.293: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset7-v30-7-4 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-4 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset7-v30-7-4 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-4 /> | ||
| − | ==== Scenario 7.4 - MBH_300_vrijetekstproduct==== | + | ==== Scenario 7.4 - MBH_300_vrijetekstproduct-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_vrijetekstproduct_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_vrijetekstproduct_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 9.818: | Regel 10.303: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_vrijetekstproduct_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 15:50 uur | |style="background-color: white;"|T - 1 dag om 15:50 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.839: | Regel 10.324: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ProductNaam |
|style="background-color: white;"|Jemperli 500 mg/ 10 mL | |style="background-color: white;"|Jemperli 500 mg/ 10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.856: | Regel 10.341: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per 3 weken 1 stuk, Intraveneus |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 9.864: | Regel 10.349: | ||
|style="background-color: white;"|1 maal per 3 weken 1 stuk | |style="background-color: white;"|1 maal per 3 weken 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_vrijetekstproduct-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 9.882: | Regel 10.367: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-4 /><section end=mg-mp-smg-tst-TA-Scenarioset7-v30-7-4 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset7-v30-7-4 /><section end=mg-mp-smg-tst-TA-Scenarioset7-v30-7-4 /> | ||
== TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | == TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)== | ||
| Regel 9.927: | Regel 10.415: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset7-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset7-v30 /> | |}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset7-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset7-v30 /> | ||
| − | ==== Scenario 7 - MBH_300_magistraalalleingredienten==== | + | ==== Scenario 7 - MBH_300_magistraalalleingredienten-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraalalleingredienten_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraalalleingredienten_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 9.937: | Regel 10.425: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:00 uur | |style="background-color: white;"|T om 13:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.958: | Regel 10.446: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="11"| | |rowspan="11"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.974: | Regel 10.462: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.984: | Regel 10.472: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 9.995: | Regel 10.483: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 10.003: | Regel 10.491: | ||
|style="background-color: white;"|Zo nodig | |style="background-color: white;"|Zo nodig | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraalalleingredienten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 7 - MBH_300_magistraalactieveingredient==== | + | ==== Scenario 7 - MBH_300_magistraalactieveingredient-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraalactieveingredient_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraalactieveingredient_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 10.023: | Regel 10.511: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:05 uur | |style="background-color: white;"|T om 13:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.044: | Regel 10.532: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.060: | Regel 10.548: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.071: | Regel 10.559: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 10.079: | Regel 10.567: | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraalactieveingredient-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 7 - MBH_300_magistraal90miljoennr==== | + | ==== Scenario 7 - MBH_300_magistraal90miljoennr-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraal90miljoennr_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_magistraal90miljoennr_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 10.099: | Regel 10.587: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T om 13:08 uur | |style="background-color: white;"|T om 13:08 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.120: | Regel 10.608: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|Geneesmiddel - | + | |colspan="5"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="8"| | |rowspan="8"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductCode |
|style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ProductNaam |
|style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.139: | Regel 10.627: | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|IngredientCode |
|style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.150: | Regel 10.638: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 10.158: | Regel 10.646: | ||
|style="background-color: white;"|1 maal per dag | |style="background-color: white;"|1 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_magistraal90miljoennr-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
| − | ==== Scenario 7 - MBH_300_vrijetekstproduct==== | + | ==== Scenario 7 - MBH_300_vrijetekstproduct-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_vrijetekstproduct_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_vrijetekstproduct_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 10.178: | Regel 10.666: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_vrijetekstproduct_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T - 1 dag om 15:50 uur | |style="background-color: white;"|T - 1 dag om 15:50 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.199: | Regel 10.687: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - ProductSpecificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ProductNaam |
|style="background-color: white;"|Jemperli 500 mg/ 10 mL | |style="background-color: white;"|Jemperli 500 mg/ 10 mL | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.216: | Regel 10.704: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per 3 weken 1 stuk, Intraveneus |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 10.224: | Regel 10.712: | ||
|style="background-color: white;"|1 maal per 3 weken 1 stuk | |style="background-color: white;"|1 maal per 3 weken 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_vrijetekstproduct_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_vrijetekstproduct_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_vrijetekstproduct (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_vrijetekstproduct-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 10.242: | Regel 10.730: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset7-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset7-v30 /> | |}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset7-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset7-v30 /> | ||
== TEST Medicatiegegevens TA Scenarioset 10 (ZI)== | == TEST Medicatiegegevens TA Scenarioset 10 (ZI)== | ||
| Regel 10.287: | Regel 10.778: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mg-mp-smg-tst-TA-Scenarioset10-v30-10-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset10-v30-10-1 /> | |}<section end=patient-mg-mp-smg-tst-TA-Scenarioset10-v30-10-1 /><section begin=mbhs-mg-mp-smg-tst-TA-Scenarioset10-v30-10-1 /> | ||
| − | ==== Scenario 10.1 - MBH_300_ZINRvoorschrijven==== | + | ==== Scenario 10.1 - MBH_300_ZINRvoorschrijven-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 10.297: | Regel 10.788: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 14:05 uur | |style="background-color: white;"|T om 14:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.318: | Regel 10.809: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"|INDAPAMIDE | + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|INDAPAMIDE | + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 10.337: | Regel 10.828: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 10.345: | Regel 10.836: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 10.363: | Regel 10.854: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset10-v30-10-1 /><section end=mg-mp-smg-tst-TA-Scenarioset10-v30-10-1 /> | |}<section end=mbhs-mg-mp-smg-tst-TA-Scenarioset10-v30-10-1 /><section end=mg-mp-smg-tst-TA-Scenarioset10-v30-10-1 /> | ||
== TEST Medicatiegegevens TA Scenarioset 10 (ZI)== | == TEST Medicatiegegevens TA Scenarioset 10 (ZI)== | ||
| Regel 10.408: | Regel 10.902: | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
|}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset10-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset10-v30 /> | |}<section end=patient-mgsets-mp-smg-tst-TA-Scenarioset10-v30 /><section begin=mbhs-mgsets-mp-smg-tst-TA-Scenarioset10-v30 /> | ||
| − | ==== Scenario 10 - MBH_300_ZINRvoorschrijven==== | + | ==== Scenario 10 - MBH_300_ZINRvoorschrijven-tmgs==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA-tmgs |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="3" width="25%"| Gegevenselement | |colspan="3" width="25%"| Gegevenselement | ||
| Regel 10.418: | Regel 10.912: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|RegistratieDatumTijd |
|style="background-color: white;"|T om 14:05 uur | |style="background-color: white;"|T om 14:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 10.439: | Regel 10.933: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - primaire code | |colspan="3"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"|INDAPAMIDE | + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"|INDAPAMIDE | + | |style="background-color: white;"|INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Geneesmiddel - generiekere code | |colspan="3"|Geneesmiddel - generiekere code | ||
| Regel 10.458: | Regel 10.952: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Omschrijving | |colspan="2"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Toedieningsweg | |colspan="2"|Toedieningsweg | ||
| Regel 10.466: | Regel 10.960: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Identificatie | |colspan="2"|Identificatie | ||
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|MBH identificatie | |colspan="3"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | + | |style="background-color: white;"|MBH_300_ZINRvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
==== Bouwstenen ==== | ==== Bouwstenen ==== | ||
| Regel 10.484: | Regel 10.978: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|<span id=" | + | |colspan="4"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset10-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset10-v30 /> | |}<section end=mbhs-mgsets-mp-smg-tst-TA-Scenarioset10-v30 /><section end=mgsets-mp-smg-tst-TA-Scenarioset10-v30 /> | ||
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] | ||
Huidige versie van 24 feb 2026 om 14:03
Inhoud
- 1 Addenda voor inhoudelijke gegevens
- 1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
- 1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
- 1.3 TEST Medicatiegegevens TA Scenarioset 1
- 1.4 TEST Medicatiegegevens TA Scenarioset 1
- 1.5 TEST Medicatiegegevens TA Scenarioset 1
- 1.6 TEST Medicatiegegevens TA Scenarioset 1
- 1.7 TEST Medicatiegegevens TA Scenarioset 1
- 1.8 TEST Medicatiegegevens TA Scenarioset 1
- 1.9 TEST Medicatiegegevens TA Scenarioset 1
- 1.10 TEST Medicatiegegevens TA Scenarioset 2
- 1.11 TEST Medicatiegegevens TA Scenarioset 2
- 1.12 TEST Medicatiegegevens TA Scenarioset 2
- 1.13 TEST Medicatiegegevens TA Scenarioset 2
- 1.14 TEST Medicatiegegevens TA Scenarioset 2
- 1.15 TEST Medicatiegegevens TA Scenarioset 2
- 1.16 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.17 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.18 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.18.1 Scenario 3 - MBH_300_stoppen-tmgs
- 1.18.2 Scenario 3 - MBH_300_wijzigen_verhoging-tmgs
- 1.18.3 Scenario 3 - MBH_300_wijzigen_verlaging-tmgs
- 1.18.4 Scenario 3 - MBH_300_onderbreken-tmgs
- 1.18.5 Scenario 3 - MBH_300_TAwijzigen-tmgs
- 1.18.6 Scenario 3 - MBH_300_annuleren-tmgs
- 1.18.7 Scenario 3 - MBH_300_stoppen_parallele_TA-tmgs
- 1.18.8 Scenario 3 - MBH_300_MTDopschorten-tmgs
- 1.18.9 Scenario 3 - mbh_300_AfwijkendeToediening-tmgs
- 1.18.10 Scenario 3 - MBH_300_wijzigen_correctie-tmgs
- 1.18.11 Scenario 3 - MBH_300_CorrectieToediening -tmgs
- 1.18.12 Bouwstenen
- 1.19 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.20 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.21 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.22 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.23 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.24 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.25 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.26 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.27 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
- 1.28 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.29 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.30 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.31 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.32 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.33 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.33.1 Scenario 6 - MBH_300_variabelefrequentie-tmgs
- 1.33.2 Scenario 6 - MBH_300_interval-tmgs
- 1.33.3 Scenario 6 - MBH_300_variabelehoeveelheid-tmgs
- 1.33.4 Scenario 6 - MBH_300_zonderkeerdosis-tmgs
- 1.33.5 Scenario 6 - MBH_300_bijzonderekeerdosis-tmgs
- 1.33.6 Scenario 6 - MBH_300_variabelehoeveelheid2-tmgs
- 1.33.7 Scenario 6 - MBH_300_tijdstippen_flexibel-tmgs
- 1.33.8 Scenario 6 - MBH_300_weekdagen-tmgs
- 1.33.9 Scenario 6 - MBH_300_dagdeel-tmgs
- 1.33.10 Scenario 6 - MBH_300_cyclischschema-tmgs
- 1.33.11 Scenario 6 - MBH_300_afbouwschema-tmgs
- 1.33.12 Scenario 6 - MBH_300_variabelehoeveelheidenmaximum-tmgs
- 1.33.13 Scenario 6 - MBH_300_toedieningssnelheid-tmgs
- 1.33.14 Scenario 6 - MBH_300_toedieningsduur-tmgs
- 1.33.15 Scenario 6 - MBH_300_zonodig-tmgs
- 1.33.16 Scenario 6 - MBH_300_tijdstippen_niet_flexibel-tmgs
- 1.33.17 Scenario 6 - MBH_300_redundantefrequentie-tmgs
- 1.33.18 Bouwstenen
- 1.34 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.35 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.36 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.37 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.38 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.39 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.40 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.41 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.42 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.43 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.44 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.45 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
- 1.46 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
- 1.47 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
- 1.48 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
- 1.49 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
- 1.50 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
- 1.51 TEST Medicatiegegevens TA Scenarioset 10 (ZI)
- 1.52 TEST Medicatiegegevens TA Scenarioset 10 (ZI)
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset
| Scenario | Screenshots? | Beschrijving | MBH id | TA id |
| 1 | MBH_300_start_eind-tmgs MBH_300_start_duur-tmgs MBH_300_chronisch-tmgs MBH_300_start_duur2-tmgs MBH_300_dosis_stuks-tmgs MBH_300_start_criterium-tmgs |
MBH_300_start_eind_TA-tmgs MBH_300_start_duur_TA-tmgs MBH_300_chronisch_TA-tmgs MBH_300_start_duur2_TA-tmgs MBH_300_dosis_stuks_TA-tmgs MBH_300_start_criterium_TA-tmgs | ||
| 2 | MBH_300_aanvullendeinstructie-tmgs MBH_300_toelichting-tmgs MBH_300_redenvanvoorschrijven-tmgs MBH_300_aanvullendeinformatiewensen-tmgs MBH_300_Toedieningsweg-tmgs |
MBH_300_aanvullendeinstructie_TA-tmgs MBH_300_toelichting_TA-tmgs MBH_300_redenvanvoorschrijven_TA-tmgs MBH_300_aanvullendeinformatiewensen_TA-tmgs MBH_300_Toedieningsweg_TA-tmgs | ||
| 3 | MBH_300_stoppen-tmgs MBH_300_wijzigen_verhoging-tmgs MBH_300_wijzigen_verlaging-tmgs MBH_300_onderbreken-tmgs MBH_300_TAwijzigen-tmgs MBH_300_annuleren-tmgs MBH_300_stoppen_parallele_TA-tmgs MBH_300_MTDopschorten-tmgs mbh_300_AfwijkendeToediening-tmgs MBH_300_wijzigen_correctie-tmgs MBH_300_CorrectieToediening -tmgs |
MBH_300_stoppen_TA_start-tmgs MBH_300_stoppen_TA_staken-tmgs MBH_300_wijzigen_verhoging_TA_start-tmgs MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs MBH_300_wijzigen_verhoging_TA_techstaken-tmgs MBH_300_wijzigen_verlaging_TA_start-tmgs MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs MBH_300_wijzigen_verlaging_TA_techstaken-tmgs MBH_300_onderbreken_TA_start-tmgs MBH_300_onderbreken_TA_onderbreken-tmgs MBH_300_TAwijzigen_TA_start-tmgs MBH_300_TAwijzigen_TA_techstaken-tmgs MBH_300_TAwijzigen_TA_anderePRK-tmgs MBH_300_annuleren_TA_starten-tmgs MBH_300_annuleren_TA_geannuleerd-tmgs MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs MBH_300_MTDopschorten_TA-tmgs mbh_300_AfwijkendeToediening_TA-tmgs MBH_300_wijzigen_correctie_TA-tmgs MBH_300_wijzigen_correctie_TA_stopTA-tmgs MBH_300_wijzigen_correctie_TA_correctieTA-tmgs MBH_300_CorrectieToediening_TA-tmgs | ||
| 6 | MBH_300_variabelefrequentie-tmgs MBH_300_interval-tmgs MBH_300_variabelehoeveelheid-tmgs MBH_300_zonderkeerdosis-tmgs MBH_300_bijzonderekeerdosis-tmgs MBH_300_variabelehoeveelheid2-tmgs MBH_300_tijdstippen_flexibel-tmgs MBH_300_weekdagen-tmgs MBH_300_dagdeel-tmgs MBH_300_cyclischschema-tmgs MBH_300_afbouwschema-tmgs MBH_300_variabelehoeveelheidenmaximum-tmgs MBH_300_toedieningssnelheid-tmgs MBH_300_toedieningsduur-tmgs MBH_300_zonodig-tmgs MBH_300_tijdstippen_niet_flexibel-tmgs MBH_300_redundantefrequentie-tmgs |
MBH_300_variabelefrequentie_TA-tmgs MBH_300_interval_TA-tmgs MBH_300_variabelehoeveelheid_TA-tmgs MBH_300_zonderkeerdosis_TA-tmgs MBH_300_bijzonderekeerdosis_TA-tmgs MBH_300_variabelehoeveelheid2_TA-tmgs MBH_300_tijdstippen_flexibel_TA-tmgs MBH_300_weekdagen_TA-tmgs MBH_300_dagdeel_TA-tmgs MBH_300_cyclischschema_TA-tmgs MBH_300_afbouwschema_TA-tmgs MBH_300_variabelehoeveelheidenmaximum_TA-tmgs MBH_300_toedieningssnelheid_TA-tmgs MBH_300_toedieningsduur_TA-tmgs MBH_300_zonodig_TA-tmgs MBH_300_tijdstippen_niet_flexibel_TA-tmgs MBH_300_redundantefrequentie_TA-tmgs | ||
| 7 | MBH_300_magistraalalleingredienten-tmgs MBH_300_magistraalactieveingredient-tmgs MBH_300_magistraal90miljoennr-tmgs MBH_300_vrijetekstproduct-tmgs |
MBH_300_magistraalalleingredienten_TA-tmgs MBH_300_magistraalactieveingredient_TA-tmgs MBH_300_magistraal90miljoennr_TA-tmgs MBH_300_vrijetekstproduct_TA-tmgs | ||
| 10 | MBH_300_ZINRvoorschrijven-tmgs | MBH_300_ZINRvoorschrijven_TA-tmgs |
1.1.2 Scenarioset 1
| Scenario | Screenshots? | Beschrijving | MBH id | TA id |
| 1.1* | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ einddatum). | Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum |
MBH_300_start_eind-tmgs | MBH_300_start_eind_TA-tmgs |
| 1.2a* | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). | Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken) |
MBH_300_start_duur-tmgs | MBH_300_start_duur_TA-tmgs |
| 1.2b* | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode ingevoerd kan worden (ingangsdatum/ duur). | Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen) |
MBH_300_start_duur2-tmgs | MBH_300_start_duur2_TA-tmgs |
| 1.3 | Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie) |
MBH_300_chronisch-tmgs | MBH_300_chronisch_TA-tmgs | |
| 1.4 | Toedieningsafspraak met eenheid 'dosis/stuks' |
MBH_300_dosis_stuks-tmgs | MBH_300_dosis_stuks_TA-tmgs | |
| 1.6 | Maak screenshot(s) waarop zichtbaar is dat de gebruiksperiode criterium ingevoerd kan worden | Toedieningsafspraak met gebruiksperiode criterium | MBH_300_start_criterium-tmgs | MBH_300_start_criterium_TA-tmgs |
1.1.3 Scenarioset 2
| Scenario | Screenshots? | Beschrijving | MBH id | TA id |
| 2.1 | Maak screenshot(s) waaruit blijkt dat een 'aanvullende instructie' ingevoerd kan worden (als vrije tekst en/of uit keuze lijstje) | Aanvullende instructie | MBH_300_aanvullendeinstructie-tmgs | MBH_300_aanvullendeinstructie_TA-tmgs |
| 2.2 | Maak screenshot(s) waaruit blijkt dat een 'toelichting' ingevoerd kan worden | Toelichting | MBH_300_toelichting-tmgs | MBH_300_toelichting_TA-tmgs |
| 2.3 | Maak screenshot(s) van de melding/waarschuwing indien de reden van voorschrijven niet wordt ingevuld. | Reden van voorschrijven | MBH_300_redenvanvoorschrijven-tmgs | MBH_300_redenvanvoorschrijven_TA-tmgs |
| 2.4 | Maak screenshot(s) waarop de lijst met concepten voor 'aanvullende informatie' zichtbaar is | Aanvullende informatie | MBH_300_aanvullendeinformatiewensen-tmgs | MBH_300_aanvullendeinformatiewensen_TA-tmgs |
| 2.5 | Maak screenshot(s) waarop de toelichting zichtbaar is | Toedieningsweg | MBH_300_Toedieningsweg-tmgs | MBH_300_Toedieningsweg_TA-tmgs |
1.1.4 Scenarioset 3
| Scenario | Screenshots? | Beschrijving | MBH id | TA id |
| 3.1 | Stop-toedieningsafspraak, met reden staken |
MBH_300_stoppen-tmgs | MBH_300_stoppen_TA_start-tmgs MBH_300_stoppen_TA_staken-tmgs | |
| 3.2 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Wijziging toedieningsafspraak, met reden wijziging |
MBH_300_wijzigen_verhoging-tmgs | MBH_300_wijzigen_verhoging_TA_start-tmgs MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs MBH_300_wijzigen_verhoging_TA_techstaken-tmgs |
| 3.3 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Wijziging toedieningsafspraak, met reden wijziging |
MBH_300_wijzigen_verlaging-tmgs | MBH_300_wijzigen_verlaging_TA_start-tmgs MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs MBH_300_wijzigen_verlaging_TA_techstaken-tmgs |
| 3.4 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt | Onderbreken toedieningsafspraak |
MBH_300_onderbreken-tmgs | MBH_300_onderbreken_TA_start-tmgs MBH_300_onderbreken_TA_onderbreken-tmgs |
| 3.5 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt |
Tweede MVE ivm TA met nieuwe PRK. |
MBH_300_TAwijzigen-tmgs | MBH_300_TAwijzigen_TA_start-tmgs MBH_300_TAwijzigen_TA_techstaken-tmgs MBH_300_TAwijzigen_TA_anderePRK-tmgs |
| 3.6 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt. | Annuleren toedieningsafspraak | MBH_300_annuleren-tmgs | MBH_300_annuleren_TA_starten-tmgs MBH_300_annuleren_TA_geannuleerd-tmgs |
| 3.7 | Maak screenshot(s) waarin de samenhang en actualiteit van de bouwstenen/de medicamenteuze behandeling inzichtelijk wordt. | Stoppen van een TA bij twee parallelle TA's | MBH_300_stoppen_parallele_TA-tmgs | MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs |
| 3.10 | TA waarin een correctie plaatsvindt | MBH_300_wijzigen_correctie-tmgs | MBH_300_wijzigen_correctie_TA-tmgs MBH_300_wijzigen_correctie_TA_stopTA-tmgs MBH_300_wijzigen_correctie_TA_correctieTA-tmgs | |
| 3.11 | TA waaronder een MTD wordt opgeschort | MBH_300_MTDopschorten-tmgs | MBH_300_MTDopschorten_TA-tmgs | |
| 3.12 | TA waaronder een MTD een afwijkende toegediende hoeveelheid heeft | mbh_300_AfwijkendeToediening-tmgs | mbh_300_AfwijkendeToediening_TA-tmgs | |
| 3.13 | TA waaronder een MTD een correctie toediening heeft | MBH_300_CorrectieToediening -tmgs | MBH_300_CorrectieToediening_TA-tmgs |
1.1.5 Scenarioset 6
| Scenario | Screenshots? | Beschrijving | MBH id | TA id |
| 6.1 | Variabele frequentie | MBH_300_variabelefrequentie-tmgs | MBH_300_variabelefrequentie_TA-tmgs | |
| 6.2 | Interval | MBH_300_interval-tmgs | MBH_300_interval_TA-tmgs | |
| 6.3 | Variabele hoeveelheid (1) | MBH_300_variabelehoeveelheid-tmgs | MBH_300_variabelehoeveelheid_TA-tmgs | |
| 6.4 | Zonder keerdosis | MBH_300_zonderkeerdosis-tmgs | MBH_300_zonderkeerdosis_TA-tmgs | |
| 6.5 | Bijzondere keerdosis | MBH_300_bijzonderekeerdosis-tmgs | MBH_300_bijzonderekeerdosis_TA-tmgs | |
| 6.6 | Variabele hoeveelheid (2) | MBH_300_variabelehoeveelheid2-tmgs | MBH_300_variabelehoeveelheid2_TA-tmgs | |
| 6.7a | Maak screenshot(s) waarop zichtbaar is dat tijdstip gekozen kan worden | Tijdstippen flexibel | MBH_300_tijdstippen_flexibel-tmgs | MBH_300_tijdstippen_flexibel_TA-tmgs |
| 6.7b | Tijdstippen niet flexibel | MBH_300_tijdstippen_niet_flexibel-tmgs | MBH_300_tijdstippen_niet_flexibel_TA-tmgs | |
| 6.8 | Maak screenshot(s) waarop zichtbaar is dat weekdagen gekozen kunnen worden | Weekdagen | MBH_300_weekdagen-tmgs | MBH_300_weekdagen_TA-tmgs |
| 6.9 | Maak screenshot(s) waarop zichtbaar is dat dagdelen gekozen kunnen worden | Dagdeel | MBH_300_dagdeel-tmgs | MBH_300_dagdeel_TA-tmgs |
| 6.10 | Maak screenshot(s) waarop zichtbaar is dat een cyclisch schema ingevuld kan worden | Cyclisch schema | MBH_300_cyclischschema-tmgs | MBH_300_cyclischschema_TA-tmgs |
| 6.11 | Maak screenshot(s) waarop zichtbaar is dat een doseerschema (met doseerduur) ingevoerd kan worden | Afbouw schema en doseerduur | MBH_300_afbouwschema-tmgs | MBH_300_afbouwschema_TA-tmgs |
| 6.12 | Variabele hoeveelheid en maximum | MBH_300_variabelehoeveelheidenmaximum-tmgs | MBH_300_variabelehoeveelheidenmaximum_TA-tmgs | |
| 6.13 | Toedieningssnelheid | MBH_300_toedieningssnelheid-tmgs | MBH_300_toedieningssnelheid_TA-tmgs | |
| 6.14 | Toedieningsduur | MBH_300_toedieningsduur-tmgs | MBH_300_toedieningsduur_TA-tmgs | |
| 6.15 | Maak screenshot(s) waarop de lijst met concepten voor 'zo nodig' zichtbaar zijn (incl. eventueel overige concepten of eigen invoer mogelijkheid) | Zo nodig | MBH_300_zonodig-tmgs | MBH_300_zonodig_TA-tmgs |
| 6.16 | Redundante frequentie | MBH_300_redundantefrequentie-tmgs | MBH_300_redundantefrequentie_TA-tmgs |
1.1.6 Scenarioset 7
| Scenario | Screenshots? | Beschrijving | MBH id | TA id |
| 7.1 | Maak screenshot(s) waarop zichtbaar is dat er ingrediënten ingevoerd/gekozen kunnen worden | Alle ingrediënten | MBH_300_magistraalalleingredienten-tmgs | MBH_300_magistraalalleingredienten_TA-tmgs |
| 7.2 | Maak screenshot(s) waarop zichtbaar is dat er een ingrediënt ingevoerd/gekozen kan worden | Actief ingrediënt | MBH_300_magistraalactieveingredient-tmgs | MBH_300_magistraalactieveingredient_TA-tmgs |
| 7.3 | Maak screenshot(s) waarop zichtbaar is dat het eigen artikel gekozen wordt | 90 miljoen nummer | MBH_300_magistraal90miljoennr-tmgs | MBH_300_magistraal90miljoennr_TA-tmgs |
| 7.4 | Maak screenshot(s) waarop zichtbaar is dat het vrije tekst product gekozen wordt | Vrije tekst product | MBH_300_vrijetekstproduct-tmgs | MBH_300_vrijetekstproduct_TA-tmgs |
1.1.7 Scenarioset 10
| Scenario | Screenshots? | Beschrijving | MBH id | TA id |
| 10.1 | ZI-nr geneesmiddel | MBH_300_ZINRvoorschrijven-tmgs | MBH_300_ZINRvoorschrijven_TA-tmgs |
1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
1.2.1 Scenarioset
| Scenario | Beschrijving | MBH id | TA id |
| 1 | MBH_300_start_eind-tmgs MBH_300_start_duur-tmgs MBH_300_chronisch-tmgs MBH_300_start_duur2-tmgs MBH_300_dosis_stuks-tmgs MBH_300_start_criterium-tmgs |
MBH_300_start_eind_TA-tmgs MBH_300_start_duur_TA-tmgs MBH_300_chronisch_TA-tmgs MBH_300_start_duur2_TA-tmgs MBH_300_dosis_stuks_TA-tmgs MBH_300_start_criterium_TA-tmgs | |
| 2 | MBH_300_aanvullendeinstructie-tmgs MBH_300_toelichting-tmgs MBH_300_redenvanvoorschrijven-tmgs MBH_300_aanvullendeinformatiewensen-tmgs MBH_300_Toedieningsweg-tmgs |
MBH_300_aanvullendeinstructie_TA-tmgs MBH_300_toelichting_TA-tmgs MBH_300_redenvanvoorschrijven_TA-tmgs MBH_300_aanvullendeinformatiewensen_TA-tmgs MBH_300_Toedieningsweg_TA-tmgs | |
| 3 | MBH_300_stoppen-tmgs MBH_300_wijzigen_verhoging-tmgs MBH_300_wijzigen_verlaging-tmgs MBH_300_onderbreken-tmgs MBH_300_TAwijzigen-tmgs MBH_300_annuleren-tmgs MBH_300_stoppen_parallele_TA-tmgs MBH_300_MTDopschorten-tmgs mbh_300_AfwijkendeToediening-tmgs MBH_300_wijzigen_correctie-tmgs MBH_300_CorrectieToediening -tmgs |
MBH_300_stoppen_TA_start-tmgs MBH_300_stoppen_TA_staken-tmgs MBH_300_wijzigen_verhoging_TA_start-tmgs MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs MBH_300_wijzigen_verhoging_TA_techstaken-tmgs MBH_300_wijzigen_verlaging_TA_start-tmgs MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs MBH_300_wijzigen_verlaging_TA_techstaken-tmgs MBH_300_onderbreken_TA_start-tmgs MBH_300_onderbreken_TA_onderbreken-tmgs MBH_300_TAwijzigen_TA_start-tmgs MBH_300_TAwijzigen_TA_techstaken-tmgs MBH_300_TAwijzigen_TA_anderePRK-tmgs MBH_300_annuleren_TA_starten-tmgs MBH_300_annuleren_TA_geannuleerd-tmgs MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs MBH_300_MTDopschorten_TA-tmgs mbh_300_AfwijkendeToediening_TA-tmgs MBH_300_wijzigen_correctie_TA-tmgs MBH_300_wijzigen_correctie_TA_stopTA-tmgs MBH_300_wijzigen_correctie_TA_correctieTA-tmgs MBH_300_CorrectieToediening_TA-tmgs | |
| 6 | MBH_300_variabelefrequentie-tmgs MBH_300_interval-tmgs MBH_300_variabelehoeveelheid-tmgs MBH_300_zonderkeerdosis-tmgs MBH_300_bijzonderekeerdosis-tmgs MBH_300_variabelehoeveelheid2-tmgs MBH_300_tijdstippen_flexibel-tmgs MBH_300_weekdagen-tmgs MBH_300_dagdeel-tmgs MBH_300_cyclischschema-tmgs MBH_300_afbouwschema-tmgs MBH_300_variabelehoeveelheidenmaximum-tmgs MBH_300_toedieningssnelheid-tmgs MBH_300_toedieningsduur-tmgs MBH_300_zonodig-tmgs MBH_300_tijdstippen_niet_flexibel-tmgs MBH_300_redundantefrequentie-tmgs |
MBH_300_variabelefrequentie_TA-tmgs MBH_300_interval_TA-tmgs MBH_300_variabelehoeveelheid_TA-tmgs MBH_300_zonderkeerdosis_TA-tmgs MBH_300_bijzonderekeerdosis_TA-tmgs MBH_300_variabelehoeveelheid2_TA-tmgs MBH_300_tijdstippen_flexibel_TA-tmgs MBH_300_weekdagen_TA-tmgs MBH_300_dagdeel_TA-tmgs MBH_300_cyclischschema_TA-tmgs MBH_300_afbouwschema_TA-tmgs MBH_300_variabelehoeveelheidenmaximum_TA-tmgs MBH_300_toedieningssnelheid_TA-tmgs MBH_300_toedieningsduur_TA-tmgs MBH_300_zonodig_TA-tmgs MBH_300_tijdstippen_niet_flexibel_TA-tmgs MBH_300_redundantefrequentie_TA-tmgs | |
| 7 | MBH_300_magistraalalleingredienten-tmgs MBH_300_magistraalactieveingredient-tmgs MBH_300_magistraal90miljoennr-tmgs MBH_300_vrijetekstproduct-tmgs |
MBH_300_magistraalalleingredienten_TA-tmgs MBH_300_magistraalactieveingredient_TA-tmgs MBH_300_magistraal90miljoennr_TA-tmgs MBH_300_vrijetekstproduct_TA-tmgs | |
| 10 | MBH_300_ZINRvoorschrijven-tmgs | MBH_300_ZINRvoorschrijven_TA-tmgs |
1.2.2 Scenarioset 1
| Scenario | Beschrijving | MBH id | TA id |
| 1.1 | Toedieningsafspraak gebruiksperiode ingangsdatum en einddatum |
MBH_300_start_eind-tmgs | MBH_300_start_eind_TA-tmgs |
| 1.2a | Toedieningsafspraak gebruiksperiode ingangsdatum en duur (weken) |
MBH_300_start_duur-tmgs | MBH_300_start_duur_TA-tmgs |
| 1.2b | Toedieningsafspraak gebruiksperiode ingangsdatum en duur (dagen) |
MBH_300_start_duur2-tmgs | MBH_300_start_duur2_TA-tmgs |
| 1.3 | Toedieningsafspraak gebruiksperiode ingangsdatum (chronische medicatie) |
MBH_300_chronisch-tmgs | MBH_300_chronisch_TA-tmgs |
| 1.4 | Toedieningsafspraak met eenheid 'dosis/stuks' |
MBH_300_dosis_stuks-tmgs | MBH_300_dosis_stuks_TA-tmgs |
| 1.6 | Toedieningsafspraak met gebruiksperiode criterium | MBH_300_start_criterium-tmgs | MBH_300_start_criterium_TA-tmgs |
1.2.3 Scenarioset 2
| Scenario | Beschrijving | MBH id | TA id |
| 2.1 | Aanvullende instructie | MBH_300_aanvullendeinstructie-tmgs | MBH_300_aanvullendeinstructie_TA-tmgs |
| 2.2 | Toelichting | MBH_300_toelichting-tmgs | MBH_300_toelichting_TA-tmgs |
| 2.3 | Reden van voorschrijven | MBH_300_redenvanvoorschrijven-tmgs | MBH_300_redenvanvoorschrijven_TA-tmgs |
| 2.4 | Aanvullende informatie | MBH_300_aanvullendeinformatiewensen-tmgs | MBH_300_aanvullendeinformatiewensen_TA-tmgs |
| 2.5 | Toedieningsweg | MBH_300_Toedieningsweg-tmgs | MBH_300_Toedieningsweg_TA-tmgs |
1.2.4 Scenarioset 3
| Scenario | Beschrijving | MBH id | TA id |
| 3.1 | Stop-toedieningsafspraak, met reden staken |
MBH_300_stoppen-tmgs | MBH_300_stoppen_TA_start-tmgs MBH_300_stoppen_TA_staken-tmgs |
| 3.2 | Wijziging toedieningsafspraak, met reden wijziging |
MBH_300_wijzigen_verhoging-tmgs | MBH_300_wijzigen_verhoging_TA_start-tmgs MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs MBH_300_wijzigen_verhoging_TA_techstaken-tmgs |
| 3.3 | Wijziging toedieningsafspraak, met reden wijziging |
MBH_300_wijzigen_verlaging-tmgs | MBH_300_wijzigen_verlaging_TA_start-tmgs MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs MBH_300_wijzigen_verlaging_TA_techstaken-tmgs |
| 3.4 | Onderbreken toedieningsafspraak |
MBH_300_onderbreken-tmgs | MBH_300_onderbreken_TA_start-tmgs MBH_300_onderbreken_TA_onderbreken-tmgs |
| 3.5 | Tweede MVE ivm TA met nieuwe PRK. |
MBH_300_TAwijzigen-tmgs | MBH_300_TAwijzigen_TA_start-tmgs MBH_300_TAwijzigen_TA_techstaken-tmgs MBH_300_TAwijzigen_TA_anderePRK-tmgs |
| 3.6 | Annuleren toedieningsafspraak | MBH_300_annuleren-tmgs | MBH_300_annuleren_TA_starten-tmgs MBH_300_annuleren_TA_geannuleerd-tmgs |
| 3.7 | Stoppen van een TA bij twee parallelle TA's | MBH_300_stoppen_parallele_TA-tmgs | MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs |
| 3.10 | TA waarin een correctie plaatsvindt | MBH_300_wijzigen_correctie-tmgs | MBH_300_wijzigen_correctie_TA-tmgs MBH_300_wijzigen_correctie_TA_stopTA-tmgs MBH_300_wijzigen_correctie_TA_correctieTA-tmgs |
| 3.11 | TA waaronder een MTD wordt opgeschort | MBH_300_MTDopschorten-tmgs | MBH_300_MTDopschorten_TA-tmgs |
| 3.12 | TA waaronder een MTD een afwijkende toegediende hoeveelheid heeft | mbh_300_AfwijkendeToediening-tmgs | mbh_300_AfwijkendeToediening_TA-tmgs |
| 3.13 | TA waaronder een MTD een correctie toediening heeft | MBH_300_CorrectieToediening -tmgs | MBH_300_CorrectieToediening_TA-tmgs |
1.2.5 Scenarioset 6
| Scenario | Beschrijving | MBH id | TA id |
| 6.1 | Variabele frequentie | MBH_300_variabelefrequentie-tmgs | MBH_300_variabelefrequentie_TA-tmgs |
| 6.2 | Interval | MBH_300_interval-tmgs | MBH_300_interval_TA-tmgs |
| 6.3 | Variabele hoeveelheid (1) | MBH_300_variabelehoeveelheid-tmgs | MBH_300_variabelehoeveelheid_TA-tmgs |
| 6.4 | Zonder keerdosis | MBH_300_zonderkeerdosis-tmgs | MBH_300_zonderkeerdosis_TA-tmgs |
| 6.5 | Bijzondere keerdosis | MBH_300_bijzonderekeerdosis-tmgs | MBH_300_bijzonderekeerdosis_TA-tmgs |
| 6.6 | Variabele hoeveelheid (2) | MBH_300_variabelehoeveelheid2-tmgs | MBH_300_variabelehoeveelheid2_TA-tmgs |
| 6.7a | Tijdstippen flexibel | MBH_300_tijdstippen_flexibel-tmgs | MBH_300_tijdstippen_flexibel_TA-tmgs |
| 6.7b | Tijdstippen niet flexibel | MBH_300_tijdstippen_niet_flexibel-tmgs | MBH_300_tijdstippen_niet_flexibel_TA-tmgs |
| 6.8 | Weekdagen | MBH_300_weekdagen-tmgs | MBH_300_weekdagen_TA-tmgs |
| 6.9 | Dagdeel | MBH_300_dagdeel-tmgs | MBH_300_dagdeel_TA-tmgs |
| 6.10 | Cyclisch schema | MBH_300_cyclischschema-tmgs | MBH_300_cyclischschema_TA-tmgs |
| 6.11 | Afbouw schema en doseerduur | MBH_300_afbouwschema-tmgs | MBH_300_afbouwschema_TA-tmgs |
| 6.12 | Variabele hoeveelheid en maximum | MBH_300_variabelehoeveelheidenmaximum-tmgs | MBH_300_variabelehoeveelheidenmaximum_TA-tmgs |
| 6.13 | Toedieningssnelheid | MBH_300_toedieningssnelheid-tmgs | MBH_300_toedieningssnelheid_TA-tmgs |
| 6.14 | Toedieningsduur | MBH_300_toedieningsduur-tmgs | MBH_300_toedieningsduur_TA-tmgs |
| 6.15 | Zo nodig | MBH_300_zonodig-tmgs | MBH_300_zonodig_TA-tmgs |
| 6.16 | Redundante frequentie | MBH_300_redundantefrequentie-tmgs | MBH_300_redundantefrequentie_TA-tmgs |
1.2.6 Scenarioset 7
| Scenario | Beschrijving | MBH id | TA id |
| 7.1 | Alle ingrediënten | MBH_300_magistraalalleingredienten-tmgs | MBH_300_magistraalalleingredienten_TA-tmgs |
| 7.2 | Actief ingrediënt | MBH_300_magistraalactieveingredient-tmgs | MBH_300_magistraalactieveingredient_TA-tmgs |
| 7.3 | 90 miljoen nummer | MBH_300_magistraal90miljoennr-tmgs | MBH_300_magistraal90miljoennr_TA-tmgs |
| 7.4 | Vrije tekst product | MBH_300_vrijetekstproduct-tmgs | MBH_300_vrijetekstproduct_TA-tmgs |
1.2.7 Scenarioset 10
| Scenario | Beschrijving | MBH id | TA id |
| 10.1 | ZI-nr geneesmiddel | MBH_300_ZINRvoorschrijven-tmgs | MBH_300_ZINRvoorschrijven_TA-tmgs |
1.3 TEST Medicatiegegevens TA Scenarioset 1
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.3.1 Scenario 1 - MBH_300_start_eind-tmgs
| Toedieningsafspraak MBH_300_start_eind_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_eind_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 10 dagen om 12:20 uur | ||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | ||
| Ingangsdatum | T - 10 dagen | ||
| Einddatum | T - 5 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_start_eind_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_eind-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.2 Scenario 1 - MBH_300_start_duur-tmgs
| Toedieningsafspraak MBH_300_start_duur_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_duur_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 20 dagen om 12:30 uur | ||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | ||
| Ingangsdatum | T - 20 dagen | ||
| Gebruiksduur | 3 weken | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_start_duur_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_duur-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.3 Scenario 1 - MBH_300_chronisch-tmgs
| Toedieningsafspraak MBH_300_chronisch_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 30 dagen om 12:32 uur | ||
| Gebruiksperiode | Vanaf T - 30 dagen | ||
| Ingangsdatum | T - 30 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_chronisch_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.4 Scenario 1 - MBH_300_start_duur2-tmgs
| Toedieningsafspraak MBH_300_start_duur2_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_duur2_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 60 dagen om 12:30 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | ||
| Ingangsdatum | T - 60 dagen | ||
| Gebruiksduur | 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_start_duur2_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_duur2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.5 Scenario 1 - MBH_300_dosis_stuks-tmgs
| Toedieningsafspraak MBH_300_dosis_stuks_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_dosis_stuks_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 130 dagen om 12:35 uur | ||
| Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | ||
| Ingangsdatum | T - 130 dagen | ||
| Einddatum | T - 101 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 1 dosis, inhalatie | ||
| Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 2 maal per dag 1 dosis | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_dosis_stuks_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_dosis_stuks-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.6 Scenario 1 - MBH_300_start_criterium-tmgs
| Toedieningsafspraak MBH_300_start_criterium_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_criterium_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 12:20 uur | ||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 3 dagen (3 dagen voor operatie starten) | ||
| Ingangsdatum | T + 1 dag | ||
| Gebruiksduur | 3 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | CHLOORHEXIDINE DIGLUCONAAT CREME 1% (code = '1189921' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_start_criterium_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_criterium-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.3.7 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.4 TEST Medicatiegegevens TA Scenarioset 1
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.4.1 Scenario 1.1 - MBH_300_start_eind-tmgs
| Toedieningsafspraak MBH_300_start_eind_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_eind_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 10 dagen om 12:20 uur | ||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | ||
| Ingangsdatum | T - 10 dagen | ||
| Einddatum | T - 5 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | METOCLOPRAMIDE HCL ACCORD TABLET 10MG (code = '2115468' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_start_eind_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_eind-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.4.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.5 TEST Medicatiegegevens TA Scenarioset 1
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.5.1 Scenario 1.2a - MBH_300_start_duur-tmgs
| Toedieningsafspraak MBH_300_start_duur_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_duur_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 20 dagen om 12:30 uur | ||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | ||
| Ingangsdatum | T - 20 dagen | ||
| Gebruiksduur | 3 weken | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | LISINOPRIL SANDOZ TABLET 10MG (code = '1506773' in codeSystem 'G-Standaar HPK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_start_duur_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_duur-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.5.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.6 TEST Medicatiegegevens TA Scenarioset 1
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.6.1 Scenario 1.2b - MBH_300_start_duur2-tmgs
| Toedieningsafspraak MBH_300_start_duur2_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_duur2_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 60 dagen om 12:30 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | ||
| Ingangsdatum | T - 60 dagen | ||
| Gebruiksduur | 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_start_duur2_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_duur2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.6.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.7 TEST Medicatiegegevens TA Scenarioset 1
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.7.1 Scenario 1.3 - MBH_300_chronisch-tmgs
| Toedieningsafspraak MBH_300_chronisch_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_chronisch_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 30 dagen om 12:32 uur | ||
| Gebruiksperiode | Vanaf T - 30 dagen | ||
| Ingangsdatum | T - 30 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ROTER APC TABLET (code = '202185' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_chronisch_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_chronisch-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.7.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.8 TEST Medicatiegegevens TA Scenarioset 1
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.8.1 Scenario 1.4 - MBH_300_dosis_stuks-tmgs
| Toedieningsafspraak MBH_300_dosis_stuks_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_dosis_stuks_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 130 dagen om 12:35 uur | ||
| Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | ||
| Ingangsdatum | T - 130 dagen | ||
| Einddatum | T - 101 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FLIXOTIDE DISKUS INHPDR 100MCG 60DO (code = '1029754' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 1 dosis, inhalatie | ||
| Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 2 maal per dag 1 dosis | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_dosis_stuks_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_dosis_stuks-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.8.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.9 TEST Medicatiegegevens TA Scenarioset 1
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Brugge | |||
| Identificatienummer | 999900419 [BSN] | |||
| Geboortedatum | 16 okt 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.9.1 Scenario 1.6 - MBH_300_start_criterium-tmgs
| Toedieningsafspraak MBH_300_start_criterium_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_start_criterium_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 12:20 uur | ||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 3 dagen (3 dagen voor operatie starten) | ||
| Ingangsdatum | T + 1 dag | ||
| Gebruiksduur | 3 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | CHLOORHEXIDINE DIGLUCONAAT CREME 1% (code = '1189921' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | CHLOORHEXIDINE CREME 10MG/G (code = '10138' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | CHLOORHEXIDINE CREME 10MG/G (code = '26603' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_start_criterium_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_start_criterium-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.9.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.10 TEST Medicatiegegevens TA Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.10.1 Scenario 2.1 - MBH_300_aanvullendeinstructie-tmgs
| Toedieningsafspraak MBH_300_aanvullendeinstructie_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinstructie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 4 maanden om 09:00 uur | ||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 8 maanden | ||
| Ingangsdatum | T - 4 maanden | ||
| Einddatum | T + 8 maanden | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_aanvullendeinstructie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_aanvullendeinstructie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.10.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.11 TEST Medicatiegegevens TA Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.11.1 Scenario 2 - MBH_300_aanvullendeinstructie-tmgs
| Toedieningsafspraak MBH_300_aanvullendeinstructie_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinstructie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 4 maanden om 09:00 uur | ||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 8 maanden | ||
| Ingangsdatum | T - 4 maanden | ||
| Einddatum | T + 8 maanden | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_aanvullendeinstructie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_aanvullendeinstructie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.2 Scenario 2 - MBH_300_toelichting-tmgs
| Toedieningsafspraak MBH_300_toelichting_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toelichting_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 21 dagen om 09:02 uur | ||
| Gebruiksperiode | Vanaf T - 21 dagen | ||
| Ingangsdatum | T - 21 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Toelichting | In overleg met specialist | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_toelichting_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toelichting-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.3 Scenario 2 - MBH_300_redenvanvoorschrijven-tmgs
| Toedieningsafspraak MBH_300_redenvanvoorschrijven_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redenvanvoorschrijven_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 13 dagen om 09:05 uur | ||
| Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | ||
| Ingangsdatum | T - 13 dagen | ||
| Einddatum | T + 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 5 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per week 5 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_redenvanvoorschrijven_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_redenvanvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.4 Scenario 2 - MBH_300_aanvullendeinformatiewensen-tmgs
| Toedieningsafspraak MBH_300_aanvullendeinformatiewensen_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinformatiewensen_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 09:06 uur | ||
| Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | ||
| Ingangsdatum | T - 4 dagen | ||
| Einddatum | T + 5 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 19:00 1 stuk - let op, exacte toedientijd(en), Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | elke dag om 19:00 1 stuk - let op, exacte toedientijd(en) | ||
| Toelichting | Bijwerking besproken | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_aanvullendeinformatiewensen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_aanvullendeinformatiewensen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.5 Scenario 2 - MBH_300_Toedieningsweg-tmgs
| Toedieningsafspraak MBH_300_Toedieningsweg_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_Toedieningsweg_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 09:15 uur | ||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 2 dagen | ||
| Ingangsdatum | T - 5 dagen | ||
| Einddatum | T + 2 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 1 druppel, In het rechter oog, oculair | ||
| Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | ||
| Doseerinstructie | 2 maal per dag 1 druppel | ||
| Toelichting | Gebruiksinstructie gegeven | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_Toedieningsweg_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_Toedieningsweg-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.11.6 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.12 TEST Medicatiegegevens TA Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.12.1 Scenario 2.2 - MBH_300_toelichting-tmgs
| Toedieningsafspraak MBH_300_toelichting_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toelichting_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 21 dagen om 09:02 uur | ||
| Gebruiksperiode | Vanaf T - 21 dagen | ||
| Ingangsdatum | T - 21 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| Toelichting | In overleg met specialist | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_toelichting_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toelichting-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.12.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.13 TEST Medicatiegegevens TA Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.13.1 Scenario 2.3 - MBH_300_redenvanvoorschrijven-tmgs
| Toedieningsafspraak MBH_300_redenvanvoorschrijven_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redenvanvoorschrijven_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 13 dagen om 09:05 uur | ||
| Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | ||
| Ingangsdatum | T - 13 dagen | ||
| Einddatum | T + 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | METHOTREXAAT PCH TABLET 2,5MG (code = '1421778' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 5 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per week 5 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_redenvanvoorschrijven_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_redenvanvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.13.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.14 TEST Medicatiegegevens TA Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.14.1 Scenario 2.4 - MBH_300_aanvullendeinformatiewensen-tmgs
| Toedieningsafspraak MBH_300_aanvullendeinformatiewensen_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_aanvullendeinformatiewensen_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 09:06 uur | ||
| Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | ||
| Ingangsdatum | T - 4 dagen | ||
| Einddatum | T + 5 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 19:00 1 stuk - let op, exacte toedientijd(en), Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | elke dag om 19:00 1 stuk - let op, exacte toedientijd(en) | ||
| Toelichting | Bijwerking besproken | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_aanvullendeinformatiewensen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_aanvullendeinformatiewensen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.14.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.15 TEST Medicatiegegevens TA Scenarioset 2
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | C. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Coenen | |||
| Identificatienummer | 999900420 [BSN] | |||
| Geboortedatum | 17 okt 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.15.1 Scenario 2.5 - MBH_300_Toedieningsweg-tmgs
| Toedieningsafspraak MBH_300_Toedieningsweg_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_Toedieningsweg_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 09:15 uur | ||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 2 dagen | ||
| Ingangsdatum | T - 5 dagen | ||
| Einddatum | T + 2 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | SOFRADEX OORDRUPPELS (code = '644781' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 1 druppel, In het rechter oog, oculair | ||
| Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | ||
| Doseerinstructie | 2 maal per dag 1 druppel | ||
| Toelichting | Gebruiksinstructie gegeven | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_Toedieningsweg_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_Toedieningsweg-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.15.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.16 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.16.1 Scenario 3.1 - MBH_300_stoppen-tmgs
| Toedieningsafspraak MBH_300_stoppen_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 60 dagen om 09:00 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 220 dagen | ||
| Ingangsdatum | T - 60 dagen | ||
| Einddatum | T + 220 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_stoppen_TA_staken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_TA_staken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 10 dagen om 19:00 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T | ||
| Ingangsdatum | T - 60 dagen | ||
| Einddatum | T | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_MA_staken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_stoppen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_stoppen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.16.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| Zorgaanbieder APOTHEEK_JANSEN_EN_CO | |||
| ZorgaanbiederIdentificatienummer | 99901111 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek Jansen en Co | ||
1.17 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.17.1 Scenario 3.2 - MBH_300_wijzigen_verhoging-tmgs
| Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 21 dagen om 09:02 uur | ||
| Gebruiksperiode | Vanaf T - 21 dagen | ||
| Ingangsdatum | T - 21 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 09:02 uur | ||
| Gebruiksperiode | Vanaf T - 2 dagen | ||
| Ingangsdatum | T - 2 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 2 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 2 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_MA_wijzigingmetVV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_techstaken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 09:02 uur | ||
| Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | ||
| Ingangsdatum | T - 21 dagen | ||
| Einddatum | T - 3 dagen | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_MA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.17.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| Zorgaanbieder APOTHEEK_JANSEN_EN_CO | |||
| ZorgaanbiederIdentificatienummer | 99901111 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek Jansen en Co | ||
1.18 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.18.1 Scenario 3 - MBH_300_stoppen-tmgs
| Toedieningsafspraak MBH_300_stoppen_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 60 dagen om 09:00 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 220 dagen | ||
| Ingangsdatum | T - 60 dagen | ||
| Einddatum | T + 220 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_stoppen_TA_staken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_TA_staken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 10 dagen om 19:00 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T | ||
| Ingangsdatum | T - 60 dagen | ||
| Einddatum | T | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | ACETYLSALICYLZUUR CARDIO AUROBINDO DISP TABL 80MG (code = '1137891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '68632' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR DISPERTABLET 80MG (code = '117145' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_MA_staken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_stoppen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_stoppen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.2 Scenario 3 - MBH_300_wijzigen_verhoging-tmgs
| Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 21 dagen om 09:02 uur | ||
| Gebruiksperiode | Vanaf T - 21 dagen | ||
| Ingangsdatum | T - 21 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_TA_wijzigingmetMVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 09:02 uur | ||
| Gebruiksperiode | Vanaf T - 2 dagen | ||
| Ingangsdatum | T - 2 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 2 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 2 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_MA_wijzigingmetVV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_verhoging_TA_techstaken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verhoging_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 09:02 uur | ||
| Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | ||
| Ingangsdatum | T - 21 dagen | ||
| Einddatum | T - 3 dagen | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | FUROSEMIDE SANDOZ TABLET 40MG (code = '598860' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_MA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_wijzigen_verhoging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_wijzigen_verhoging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.3 Scenario 3 - MBH_300_wijzigen_verlaging-tmgs
| Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 13 dagen om 09:05 uur | ||
| Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | ||
| Ingangsdatum | T - 13 dagen | ||
| Einddatum | T + 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 09:10 uur | ||
| Gebruiksperiode | Vanaf T - 1 dag, tot en met T + 14 dagen | ||
| Ingangsdatum | T - 1 dag | ||
| Einddatum | T + 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_techstaken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 09:10 uur | ||
| Gebruiksperiode | Vanaf T - 13 dagen, tot en met T - 2 dagen | ||
| Ingangsdatum | T - 13 dagen | ||
| Einddatum | T - 2 dagen | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 2 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_MA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.4 Scenario 3 - MBH_300_onderbreken-tmgs
| Toedieningsafspraak MBH_300_onderbreken_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_onderbreken_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 09:06 uur | ||
| Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | ||
| Ingangsdatum | T - 4 dagen | ||
| Einddatum | T + 5 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_onderbreken_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_onderbreken_TA_onderbreken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_onderbreken_TA_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 19:12 uur | ||
| Gebruiksperiode | Vanaf T - 4 dagen, tot en met T - 1 dag | ||
| Ingangsdatum | T - 4 dagen | ||
| Einddatum | T - 1 dag | ||
| ToedieningsafspraakStopType | onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_onderbreken_MA_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_onderbreken_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.5 Scenario 3 - MBH_300_TAwijzigen-tmgs
| Toedieningsafspraak MBH_300_TAwijzigen_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 60 dagen om 12:30 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | ||
| Ingangsdatum | T - 60 dagen | ||
| Gebruiksduur | 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_TAwijzigen_TA_techstaken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_TAwijzigen_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 50 dagen om 12:30 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 51 dagen | ||
| Ingangsdatum | T - 60 dagen | ||
| Einddatum | T - 51 dagen | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_TAwijzigen_TA_anderePRK-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_TAwijzigen_TA_anderePRK-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 50 dagen om 12:35 uur | ||
| Gebruiksperiode | Vanaf T - 50 dagen, gedurende 18 dagen | ||
| Ingangsdatum | T - 50 dagen | ||
| Gebruiksduur | 18 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| ToedieningsafspraakRedenWijzigenOfStaken | geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.6 Scenario 3 - MBH_300_annuleren-tmgs
| Toedieningsafspraak MBH_300_annuleren_TA_starten-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_annuleren_TA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 14:10 uur | ||
| Gebruiksperiode | Vanaf T + 7 dagen om 14:10 uur, tot en met T + 49 dagen om 14:10 uur | ||
| Ingangsdatum | T + 7 dagen om 14:10 uur | ||
| Einddatum | T + 49 dagen om 14:10 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_annuleren_MA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_annuleren-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_annuleren_TA_geannuleerd-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_annuleren_TA_geannuleerd-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 14:10 uur | ||
| Gebruiksperiode | Vanaf T + 7 dagen om 14:10 uur, tot en met T + 7 dagen om 14:10 uur | ||
| Ingangsdatum | T + 7 dagen om 14:10 uur | ||
| Einddatum | T + 7 dagen om 14:10 uur | ||
| ToedieningsafspraakStopType | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_annuleren_MA_geannuleerd-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_annuleren_TA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_annuleren-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.7 Scenario 3 - MBH_300_stoppen_parallele_TA-tmgs
| Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 15 dagen om 10:15 uur | ||
| Gebruiksperiode | Vanaf T - 14 dagen, gedurende 28 dagen | ||
| Ingangsdatum | T - 14 dagen | ||
| Gebruiksduur | 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 stuk 's ochtends, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 stuk 's ochtends | ||
| Distributievorm | GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 15 dagen om 10:15 uur | ||
| Gebruiksperiode | Vanaf T - 14 dagen, gedurende 28 dagen | ||
| Ingangsdatum | T - 14 dagen | ||
| Gebruiksduur | 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij pijn 1 stuk 's avonds, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Bij pijn 1 stuk 's avonds | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 10 dagen om 10:05 uur | ||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T - 10 dagen | ||
| Ingangsdatum | T - 14 dagen | ||
| Einddatum | T - 10 dagen | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| ToedieningsafspraakRedenWijzigenOfStaken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij pijn 1 stuk 's avonds, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Bij pijn 1 stuk 's avonds | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 10 dagen om 10:05 uur | ||
| Gebruiksperiode | Vanaf T - 10 dagen, gedurende 23 dagen | ||
| Ingangsdatum | T - 10 dagen | ||
| Gebruiksduur | 23 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| ToedieningsafspraakRedenWijzigenOfStaken | geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij pijn 2 stuks 's avonds, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Bij pijn 2 stuks 's avonds | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.8 Scenario 3 - MBH_300_MTDopschorten-tmgs
| Toedieningsafspraak MBH_300_MTDopschorten_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_MTDopschorten_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 14:07:25 uur | ||
| Gebruiksperiode | Vanaf T - 5 dagen | ||
| Ingangsdatum | T - 5 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PROPRANOLOL HCL SANDOZ TABLET 80MG (code = '603678' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PROPRANOLOL TABLET 80MG (code = '5738' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 09:00 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 09:00 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_MTDopschorten_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_MTDopschorten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.9 Scenario 3 - mbh_300_AfwijkendeToediening-tmgs
| Toedieningsafspraak mbh_300_AfwijkendeToediening_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | mbh_300_AfwijkendeToediening_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 10:00 uur | ||
| Gebruiksperiode | Vanaf T - 1 dag | ||
| Ingangsdatum | T - 1 dag | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | AMLODIPINE PCH TABLET 5MG (ALS BESILAAT) (code = '2202182' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMLODIPINE TABLET 5MG (code = '123315' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 11:00 2 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 11:00 2 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | mbh_300_AfwijkendeToediening_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | mbh_300_AfwijkendeToediening-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.10 Scenario 3 - MBH_300_wijzigen_correctie-tmgs
| Toedieningsafspraak MBH_300_wijzigen_correctie_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_correctie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 7 dagen om 10:45 uur | ||
| Gebruiksperiode | Vanaf T - 7 dagen | ||
| Ingangsdatum | T - 7 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | SYMMETREL CAPSULE 100MG (code = '19380' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '485' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '1341' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 11 stuks, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 11 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_correctie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_correctie_TA_stopTA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_correctie_TA_stopTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 7 dagen om 11:59 uur | ||
| Gebruiksperiode | Vanaf T - 7 dagen, tot en met T - 7 dagen om 12:00 uur | ||
| Ingangsdatum | T - 7 dagen | ||
| Einddatum | T - 7 dagen om 12:00 uur | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| ToedieningsafspraakRedenWijzigenOfStaken | foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | SYMMETREL CAPSULE 100MG (code = '19380' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '485' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '1341' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 11 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 11 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_correctie_MA_stopMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_wijzigen_correctie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_correctie_TA_correctieTA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_correctie_TA_correctieTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 7 dagen om 11:59 uur | ||
| Gebruiksperiode | Vanaf T - 7 dagen om 12:01 uur, tot en met T + 1 dag om 00:00 uur | ||
| Ingangsdatum | T - 7 dagen om 12:01 uur | ||
| Einddatum | T + 1 dag om 00:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | SYMMETREL CAPSULE 100MG (code = '19380' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '485' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '1341' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_correctie_MA_correctieMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.11 Scenario 3 - MBH_300_CorrectieToediening -tmgs
| Toedieningsafspraak MBH_300_CorrectieToediening_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_CorrectieToediening_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 15:30 uur | ||
| Gebruiksperiode | Vanaf T - 2 dagen | ||
| Ingangsdatum | T - 2 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | TRIMETHOPRIM CF TABLET 300MG (code = '1089838' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET (code = '16020' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 13:45 1 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 13:45 1 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_CorrectieToediening_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_CorrectieToediening -tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.18.12 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| Zorgaanbieder APOTHEEK_JANSEN_EN_CO | |||
| ZorgaanbiederIdentificatienummer | 99901111 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek Jansen en Co | ||
1.19 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.19.1 Scenario 3.3 - MBH_300_wijzigen_verlaging-tmgs
| Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 13 dagen om 09:05 uur | ||
| Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | ||
| Ingangsdatum | T - 13 dagen | ||
| Einddatum | T + 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_TA_wijzigingzonderMVE-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 09:10 uur | ||
| Gebruiksperiode | Vanaf T - 1 dag, tot en met T + 14 dagen | ||
| Ingangsdatum | T - 1 dag | ||
| Einddatum | T + 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_MA_wijzigingzonderVV-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_verlaging_TA_techstaken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_verlaging_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 09:10 uur | ||
| Gebruiksperiode | Vanaf T - 13 dagen, tot en met T - 2 dagen | ||
| Ingangsdatum | T - 13 dagen | ||
| Einddatum | T - 2 dagen | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 2 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_MA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_wijzigen_verlaging_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_wijzigen_verlaging-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.19.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| Zorgaanbieder APOTHEEK_JANSEN_EN_CO | |||
| ZorgaanbiederIdentificatienummer | 99901111 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek Jansen en Co | ||
1.20 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.20.1 Scenario 3.4 - MBH_300_onderbreken-tmgs
| Toedieningsafspraak MBH_300_onderbreken_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_onderbreken_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 09:06 uur | ||
| Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | ||
| Ingangsdatum | T - 4 dagen | ||
| Einddatum | T + 5 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_onderbreken_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_onderbreken_TA_onderbreken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_onderbreken_TA_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 19:12 uur | ||
| Gebruiksperiode | Vanaf T - 4 dagen, tot en met T - 1 dag | ||
| Ingangsdatum | T - 4 dagen | ||
| Einddatum | T - 1 dag | ||
| ToedieningsafspraakStopType | onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | BROXIL CAPSULE 500MG (code = '425087' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | FENETICILLINE CAPSULE 500MG (code = '41092' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 3 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_onderbreken_MA_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_onderbreken_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_onderbreken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.20.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| Zorgaanbieder APOTHEEK_JANSEN_EN_CO | |||
| ZorgaanbiederIdentificatienummer | 99901111 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek Jansen en Co | ||
1.21 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.21.1 Scenario 3.5 - MBH_300_TAwijzigen-tmgs
| Toedieningsafspraak MBH_300_TAwijzigen_TA_start-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 60 dagen om 12:30 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | ||
| Ingangsdatum | T - 60 dagen | ||
| Gebruiksduur | 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_TAwijzigen_TA_techstaken-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_TAwijzigen_TA_techstaken-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 50 dagen om 12:30 uur | ||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 51 dagen | ||
| Ingangsdatum | T - 60 dagen | ||
| Einddatum | T - 51 dagen | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_TAwijzigen_TA_anderePRK-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_TAwijzigen_TA_anderePRK-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 50 dagen om 12:35 uur | ||
| Gebruiksperiode | Vanaf T - 50 dagen, gedurende 18 dagen | ||
| Ingangsdatum | T - 50 dagen | ||
| Gebruiksduur | 18 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| ToedieningsafspraakRedenWijzigenOfStaken | geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 2 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_TAwijzigen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_TAwijzigen_TA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_TAwijzigen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.21.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.22 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.22.1 Scenario 3.6 - MBH_300_annuleren-tmgs
| Toedieningsafspraak MBH_300_annuleren_TA_starten-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_annuleren_TA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 14:10 uur | ||
| Gebruiksperiode | Vanaf T + 7 dagen om 14:10 uur, tot en met T + 49 dagen om 14:10 uur | ||
| Ingangsdatum | T + 7 dagen om 14:10 uur | ||
| Einddatum | T + 49 dagen om 14:10 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_annuleren_MA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_annuleren-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_annuleren_TA_geannuleerd-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_annuleren_TA_geannuleerd-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 14:10 uur | ||
| Gebruiksperiode | Vanaf T + 7 dagen om 14:10 uur, tot en met T + 7 dagen om 14:10 uur | ||
| Ingangsdatum | T + 7 dagen om 14:10 uur | ||
| Einddatum | T + 7 dagen om 14:10 uur | ||
| ToedieningsafspraakStopType | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | LARIAM TABLET 250MG (code = '602574' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '25410' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MEFLOQUINE TABLET 250MG (code = '66478' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per week 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per week 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_annuleren_MA_geannuleerd-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_annuleren_TA_starten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_annuleren-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.22.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.23 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.23.1 Scenario 3.7 - MBH_300_stoppen_parallele_TA-tmgs
| Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start_GDS-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 15 dagen om 10:15 uur | ||
| Gebruiksperiode | Vanaf T - 14 dagen, gedurende 28 dagen | ||
| Ingangsdatum | T - 14 dagen | ||
| Gebruiksduur | 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 stuk 's ochtends, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 stuk 's ochtends | ||
| Distributievorm | GDS (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.3.8') | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 15 dagen om 10:15 uur | ||
| Gebruiksperiode | Vanaf T - 14 dagen, gedurende 28 dagen | ||
| Ingangsdatum | T - 14 dagen | ||
| Gebruiksduur | 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij pijn 1 stuk 's avonds, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Bij pijn 1 stuk 's avonds | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_stop_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 10 dagen om 10:05 uur | ||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T - 10 dagen | ||
| Ingangsdatum | T - 14 dagen | ||
| Einddatum | T - 10 dagen | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| ToedieningsafspraakRedenWijzigenOfStaken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 40MG (code = '878421' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij pijn 1 stuk 's avonds, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Bij pijn 1 stuk 's avonds | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start2_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 10 dagen om 10:05 uur | ||
| Gebruiksperiode | Vanaf T - 10 dagen, gedurende 23 dagen | ||
| Ingangsdatum | T - 10 dagen | ||
| Gebruiksduur | 23 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| ToedieningsafspraakRedenWijzigenOfStaken | geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | PANTOZOL TABLET MSR 20MG (code = '1163094' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij pijn 2 stuks 's avonds, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Bij pijn 2 stuks 's avonds | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_MA_start-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_stoppen_parallele_TA_TA_start_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999) | ||
| MBH identificatie | MBH_300_stoppen_parallele_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.23.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.24 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.24.1 Scenario 3.10 - MBH_300_wijzigen_correctie-tmgs
| Toedieningsafspraak MBH_300_wijzigen_correctie_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_correctie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 7 dagen om 10:45 uur | ||
| Gebruiksperiode | Vanaf T - 7 dagen | ||
| Ingangsdatum | T - 7 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | SYMMETREL CAPSULE 100MG (code = '19380' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '485' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '1341' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 11 stuks, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 11 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_correctie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_correctie_TA_stopTA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_correctie_TA_stopTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 7 dagen om 11:59 uur | ||
| Gebruiksperiode | Vanaf T - 7 dagen, tot en met T - 7 dagen om 12:00 uur | ||
| Ingangsdatum | T - 7 dagen | ||
| Einddatum | T - 7 dagen om 12:00 uur | ||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| ToedieningsafspraakRedenWijzigenOfStaken | foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT') | ||
| Geneesmiddel - primaire code | SYMMETREL CAPSULE 100MG (code = '19380' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '485' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '1341' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 11 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 11 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_correctie_MA_stopMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| RelatieToedieningsafspraak | |||
| Identificatie | MBH_300_wijzigen_correctie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| MBH identificatie | MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| Toedieningsafspraak MBH_300_wijzigen_correctie_TA_correctieTA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_wijzigen_correctie_TA_correctieTA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 7 dagen om 11:59 uur | ||
| Gebruiksperiode | Vanaf T - 7 dagen om 12:01 uur, tot en met T + 1 dag om 00:00 uur | ||
| Ingangsdatum | T - 7 dagen om 12:01 uur | ||
| Einddatum | T + 1 dag om 00:00 uur | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | SYMMETREL CAPSULE 100MG (code = '19380' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '485' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMANTADINE CAPSULE 100MG (code = '1341' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_wijzigen_correctie_MA_correctieMA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_wijzigen_correctie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.24.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.25 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.25.1 Scenario 3.11 - MBH_300_MTDopschorten-tmgs
| Toedieningsafspraak MBH_300_MTDopschorten_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_MTDopschorten_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 5 dagen om 14:07:25 uur | ||
| Gebruiksperiode | Vanaf T - 5 dagen | ||
| Ingangsdatum | T - 5 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PROPRANOLOL HCL SANDOZ TABLET 80MG (code = '603678' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PROPRANOLOL TABLET 80MG (code = '5738' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PROPRANOLOL TABLET 80MG (code = '16322' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 09:00 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 09:00 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_MTDopschorten_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_MTDopschorten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.25.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.26 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.26.1 Scenario 3.12 - mbh_300_AfwijkendeToediening-tmgs
| Toedieningsafspraak mbh_300_AfwijkendeToediening_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | mbh_300_AfwijkendeToediening_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 10:00 uur | ||
| Gebruiksperiode | Vanaf T - 1 dag | ||
| Ingangsdatum | T - 1 dag | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | AMLODIPINE PCH TABLET 5MG (ALS BESILAAT) (code = '2202182' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMLODIPINE TABLET 5MG (code = '123315' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMLODIPINE TABLET 5MG (code = '155616' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 11:00 2 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 11:00 2 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | mbh_300_AfwijkendeToediening_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | mbh_300_AfwijkendeToediening-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.26.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.27 TEST Medicatiegegevens TA Scenarioset 3 (Staken Wijzigen)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | C | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Voortman | |||
| Identificatienummer | 999908881 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.27.1 Scenario 3.13 - MBH_300_CorrectieToediening -tmgs
| Toedieningsafspraak MBH_300_CorrectieToediening_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_CorrectieToediening_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 2 dagen om 15:30 uur | ||
| Gebruiksperiode | Vanaf T - 2 dagen | ||
| Ingangsdatum | T - 2 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | ||
| Geneesmiddel - primaire code | TRIMETHOPRIM CF TABLET 300MG (code = '1089838' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET (code = '16020' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | TRIMETHOPRIM TABLET 300MG (code = '39136' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 13:45 1 stuks, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 13:45 1 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_CorrectieToediening_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_CorrectieToediening -tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.27.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_JANSEN_EN_CO | |||
| ZorgaanbiederIdentificatienummer | 99901111 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek Jansen en Co | ||
1.28 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.28.1 Scenario 6.1 - MBH_300_variabelefrequentie-tmgs
| Toedieningsafspraak MBH_300_variabelefrequentie_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelefrequentie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 16 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 à 2 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_variabelefrequentie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelefrequentie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.28.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.29 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.29.1 Scenario 6.2 - MBH_300_interval-tmgs
| Toedieningsafspraak MBH_300_interval_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_interval_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:04 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_interval_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_interval-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.29.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.30 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.30.1 Scenario 6.3 - MBH_300_variabelehoeveelheid-tmgs
| Toedieningsafspraak MBH_300_variabelehoeveelheid_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheid_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:10 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 à 2 stuks, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_variabelehoeveelheid_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheid-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.30.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.31 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.31.1 Scenario 6.4 - MBH_300_zonderkeerdosis-tmgs
| Toedieningsafspraak MBH_300_zonderkeerdosis_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_zonderkeerdosis_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:12 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag, aanbrengen, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | 3 maal per dag | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_zonderkeerdosis_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_zonderkeerdosis-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.31.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.32 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.32.1 Scenario 6.5 - MBH_300_bijzonderekeerdosis-tmgs
| Toedieningsafspraak MBH_300_bijzonderekeerdosis_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_bijzonderekeerdosis_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:15 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 0.5 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 2 maal per dag 0.5 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_bijzonderekeerdosis_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_bijzonderekeerdosis-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.32.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.33 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.33.1 Scenario 6 - MBH_300_variabelefrequentie-tmgs
| Toedieningsafspraak MBH_300_variabelefrequentie_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelefrequentie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:00 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 16 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | MIZOLLEN TABLET MGA 10MG (code = '1101099' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 à 2 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_variabelefrequentie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelefrequentie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.2 Scenario 6 - MBH_300_interval-tmgs
| Toedieningsafspraak MBH_300_interval_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_interval_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:04 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | iedere 8 uur 1 stuk - gelijke tussenpozen aanhouden | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_interval_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_interval-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.3 Scenario 6 - MBH_300_variabelehoeveelheid-tmgs
| Toedieningsafspraak MBH_300_variabelehoeveelheid_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheid_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:10 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PARACETAMOL AURO TABLET 500MG (code = '1026291' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag 1 à 2 stuks, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_variabelehoeveelheid_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheid-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.4 Scenario 6 - MBH_300_zonderkeerdosis-tmgs
| Toedieningsafspraak MBH_300_zonderkeerdosis_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_zonderkeerdosis_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:12 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | CETOMACROGOLCREME MET 10% VASELINE FAGRON (code = '1205943' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '226866' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '195758' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 3 maal per dag, aanbrengen, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | 3 maal per dag | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_zonderkeerdosis_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_zonderkeerdosis-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.5 Scenario 6 - MBH_300_bijzonderekeerdosis-tmgs
| Toedieningsafspraak MBH_300_bijzonderekeerdosis_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_bijzonderekeerdosis_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:15 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | NAPROXEN APOTEX TABLET 500MG (code = '1137778' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 0.5 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 2 maal per dag 0.5 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_bijzonderekeerdosis_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_bijzonderekeerdosis-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.6 Scenario 6 - MBH_300_variabelehoeveelheid2-tmgs
| Toedieningsafspraak MBH_300_variabelehoeveelheid2_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheid2_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:18 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL | ||
| Toedieningsweg | OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| AanvullendeInstructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_variabelehoeveelheid2_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheid2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.7 Scenario 6 - MBH_300_tijdstippen_flexibel-tmgs
| Toedieningsafspraak MBH_300_tijdstippen_flexibel_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_tijdstippen_flexibel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:24 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_tijdstippen_flexibel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_tijdstippen_flexibel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.8 Scenario 6 - MBH_300_weekdagen-tmgs
| Toedieningsafspraak MBH_300_weekdagen_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_weekdagen_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:25 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 70 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 70 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| AanvullendeInstructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | op maandag, woensdag en vrijdag | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_weekdagen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_weekdagen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.9 Scenario 6 - MBH_300_dagdeel-tmgs
| Toedieningsafspraak MBH_300_dagdeel_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_dagdeel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:27 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 stuk 's avonds, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 stuk 's avonds | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_dagdeel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_dagdeel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.10 Scenario 6 - MBH_300_cyclischschema-tmgs
| Toedieningsafspraak MBH_300_cyclischschema_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_cyclischschema_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:33 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | ||
| HerhaalperiodeCyclischSchema | 28 dagen | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_cyclischschema_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_cyclischschema-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.11 Scenario 6 - MBH_300_afbouwschema-tmgs
| Toedieningsafspraak MBH_300_afbouwschema_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afbouwschema_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:40 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 41 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 41 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | ||
| Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | ||
| Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_afbouwschema_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_afbouwschema-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.12 Scenario 6 - MBH_300_variabelehoeveelheidenmaximum-tmgs
| Toedieningsafspraak MBH_300_variabelehoeveelheidenmaximum_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheidenmaximum_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:45 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 21 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_variabelehoeveelheidenmaximum_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheidenmaximum-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.13 Scenario 6 - MBH_300_toedieningssnelheid-tmgs
| Toedieningsafspraak MBH_300_toedieningssnelheid_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningssnelheid_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:47 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 8 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 8 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | MORFINE HCL 3WATER INFVLST 5MG/ML CASS 100ML AHZ (code = '2554771' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | toedieningssnelheid: 0.2 à 0.5 ml/h, Intraveneus | ||
| Toedieningsweg | Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | toedieningssnelheid: 0.2 à 0.5 ml/h | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_toedieningssnelheid_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toedieningssnelheid-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.14 Scenario 6 - MBH_300_toedieningsduur-tmgs
| Toedieningsafspraak MBH_300_toedieningsduur_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningsduur_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:49 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk gedurende 16 uur, transdermaal | ||
| Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_toedieningsduur_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toedieningsduur-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.15 Scenario 6 - MBH_300_zonodig-tmgs
| Toedieningsafspraak MBH_300_zonodig_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_zonodig_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:57 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 27 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Zo nodig 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_zonodig_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.16 Scenario 6 - MBH_300_tijdstippen_niet_flexibel-tmgs
| Toedieningsafspraak MBH_300_tijdstippen_niet_flexibel_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_tijdstippen_niet_flexibel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 10:15 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 7 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 7 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en), oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en) | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_tijdstippen_niet_flexibel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_tijdstippen_niet_flexibel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.17 Scenario 6 - MBH_300_redundantefrequentie-tmgs
| Toedieningsafspraak MBH_300_redundantefrequentie_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redundantefrequentie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:45 uur | ||
| Gebruiksperiode | Vanaf T om 09:45 uur, gedurende 14 dagen | ||
| Ingangsdatum | T om 09:45 uur | ||
| Gebruiksduur | 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PREDNISON AURO TABLET 5MG (code = '2033682' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag om 10:00 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag om 10:00 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_redundantefrequentie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_redundantefrequentie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.33.18 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.34 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.34.1 Scenario 6.6 - MBH_300_variabelehoeveelheid2-tmgs
| Toedieningsafspraak MBH_300_variabelehoeveelheid2_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheid2_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:18 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 28 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | WATERSTOFPEROXIDE 3% CONC VOOR MONDSP FNA MR (code = '261815' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL | ||
| Toedieningsweg | OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| AanvullendeInstructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_variabelehoeveelheid2_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheid2-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.34.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.35 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.35.1 Scenario 6.7a - MBH_300_tijdstippen_flexibel-tmgs
| Toedieningsafspraak MBH_300_tijdstippen_flexibel_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_tijdstippen_flexibel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:24 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_tijdstippen_flexibel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_tijdstippen_flexibel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.35.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.36 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.36.1 Scenario 6.7b - MBH_300_tijdstippen_niet_flexibel-tmgs
| Toedieningsafspraak MBH_300_tijdstippen_niet_flexibel_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_tijdstippen_niet_flexibel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 10:15 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 7 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 7 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | METFORMINE HCL PCH TABLET 500MG (code = '693332' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en), oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, exacte toedientijd(en) | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_tijdstippen_niet_flexibel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_tijdstippen_niet_flexibel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.36.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.37 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.37.1 Scenario 6.8 - MBH_300_weekdagen-tmgs
| Toedieningsafspraak MBH_300_weekdagen_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_weekdagen_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:25 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 70 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 70 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ALDARA CREME 50MG/G IN SACHET (code = '1198521' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| AanvullendeInstructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| AanvullendeInstructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
| Doseerinstructie | op maandag, woensdag en vrijdag | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_weekdagen_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_weekdagen-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.37.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.38 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.38.1 Scenario 6.9 - MBH_300_dagdeel-tmgs
| Toedieningsafspraak MBH_300_dagdeel_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_dagdeel_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:27 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | INEGY TABLET 10/20MG (code = '1719785' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 stuk 's avonds, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 stuk 's avonds | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_dagdeel_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_dagdeel-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.38.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.39 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.39.1 Scenario 6.10 - MBH_300_cyclischschema-tmgs
| Toedieningsafspraak MBH_300_cyclischschema_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_cyclischschema_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:33 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | MARVELON TABLET (code = '416681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | ||
| HerhaalperiodeCyclischSchema | 28 dagen | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_cyclischschema_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_cyclischschema-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.39.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.40 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.40.1 Scenario 6.11 - MBH_300_afbouwschema-tmgs
| Toedieningsafspraak MBH_300_afbouwschema_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_afbouwschema_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:40 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 41 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 41 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | AFFUSINE CREME 20MG/G (code = '2292556' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | ||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | ||
| Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | ||
| Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_afbouwschema_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_afbouwschema-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.40.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.41 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.41.1 Scenario 6.12 - MBH_300_variabelehoeveelheidenmaximum-tmgs
| Toedieningsafspraak MBH_300_variabelehoeveelheidenmaximum_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_variabelehoeveelheidenmaximum_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:45 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 21 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | CODEINEFOSFAAT PCH TABLET 10MG (code = '874965' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | ||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_variabelehoeveelheidenmaximum_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_variabelehoeveelheidenmaximum-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.41.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.42 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.42.1 Scenario 6.13 - MBH_300_toedieningssnelheid-tmgs
| Toedieningsafspraak MBH_300_toedieningssnelheid_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningssnelheid_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:47 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 8 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 8 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | MORFINE HCL 3WATER INFVLST 5MG/ML CASS 100ML AHZ (code = '2554771' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | toedieningssnelheid: 0.2 à 0.5 ml/h, Intraveneus | ||
| Toedieningsweg | Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | toedieningssnelheid: 0.2 à 0.5 ml/h | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_toedieningssnelheid_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toedieningssnelheid-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.42.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.43 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.43.1 Scenario 6.14 - MBH_300_toedieningsduur-tmgs
| Toedieningsafspraak MBH_300_toedieningsduur_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_toedieningsduur_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:49 uur | ||
| Gebruiksperiode | Vanaf T | ||
| Ingangsdatum | T | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | DEPONIT T 5 PLEISTER TRANSDERMAAL 18,7MG (code = '1013602' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '228427' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '196738' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk gedurende 16 uur, transdermaal | ||
| Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
| Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_toedieningsduur_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_toedieningsduur-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.43.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.44 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.44.1 Scenario 6.15 - MBH_300_zonodig-tmgs
| Toedieningsafspraak MBH_300_zonodig_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_zonodig_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:57 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 27 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | ASPIRINE TABLET 100MG (code = '202681' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | Zo nodig 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_zonodig_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_zonodig-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.44.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.45 TEST Medicatiegegevens TA Scenarioset 6 (Doseerschemas)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hemsbergen | |||
| Identificatienummer | 999900602 [BSN] | |||
| Geboortedatum | 2 nov 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.45.1 Scenario 6.16 - MBH_300_redundantefrequentie-tmgs
| Toedieningsafspraak MBH_300_redundantefrequentie_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_redundantefrequentie_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 09:45 uur | ||
| Gebruiksperiode | Vanaf T om 09:45 uur, gedurende 14 dagen | ||
| Ingangsdatum | T om 09:45 uur | ||
| Gebruiksduur | 14 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | PREDNISON AURO TABLET 5MG (code = '2033682' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | PREDNISON TABLET 5MG (code = '8311' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | PREDNISON TABLET 5MG (code = '23817' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag om 10:00 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag om 10:00 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_redundantefrequentie_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_redundantefrequentie-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.45.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.46 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.46.1 Scenario 7.1 - MBH_300_magistraalalleingredienten-tmgs
| Toedieningsafspraak MBH_300_magistraalalleingredienten_TA-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalalleingredienten_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T om 13:00 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 31 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 31 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| IngredientCode | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 90 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | Zo nodig, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | Zo nodig | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraalalleingredienten_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraalalleingredienten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.46.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.47 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.47.1 Scenario 7.2 - MBH_300_magistraalactieveingredient-tmgs
| Toedieningsafspraak MBH_300_magistraalactieveingredient_TA-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalactieveingredient_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T om 13:05 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 70 dagen | |||
| Ingangsdatum | T + 1 dag | |||
| Einddatum | T + 70 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Vaseline 20% in cetomacrogolcrème FNA | |||
| Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
| Ingredient | ||||
| IngredientCode | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 80 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraalactieveingredient_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraalactieveingredient-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.47.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.48 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.48.1 Scenario 7.3 - MBH_300_magistraal90miljoennr-tmgs
| Toedieningsafspraak MBH_300_magistraal90miljoennr_TA-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraal90miljoennr_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T om 13:08 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 30 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductCode | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraal90miljoennr_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraal90miljoennr-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.48.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.49 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.49.1 Scenario 7.4 - MBH_300_vrijetekstproduct-tmgs
| Toedieningsafspraak MBH_300_vrijetekstproduct_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_vrijetekstproduct_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 15:50 uur | ||
| Gebruiksperiode | Vanaf T - 1 dag, gedurende 12 weken | ||
| Ingangsdatum | T - 1 dag | ||
| Gebruiksduur | 12 weken | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - ProductSpecificatie | |||
| ProductNaam | Jemperli 500 mg/ 10 mL | ||
| Omschrijving | Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per 3 weken 1 stuk, Intraveneus | ||
| Toedieningsweg | Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per 3 weken 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_vrijetekstproduct_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_vrijetekstproduct-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.49.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.50 TEST Medicatiegegevens TA Scenarioset 7 (Magistraal)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | G. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hess | |||
| Identificatienummer | 999900614 [BSN] | |||
| Geboortedatum | 3 nov 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.50.1 Scenario 7 - MBH_300_magistraalalleingredienten-tmgs
| Toedieningsafspraak MBH_300_magistraalalleingredienten_TA-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalalleingredienten_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T om 13:00 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 31 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 31 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Ingredient | ||||
| IngredientCode | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 90 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | Zo nodig, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | Zo nodig | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraalalleingredienten_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraalalleingredienten-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.50.2 Scenario 7 - MBH_300_magistraalactieveingredient-tmgs
| Toedieningsafspraak MBH_300_magistraalactieveingredient_TA-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraalactieveingredient_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T om 13:05 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 70 dagen | |||
| Ingangsdatum | T + 1 dag | |||
| Einddatum | T + 70 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Vaseline 20% in cetomacrogolcrème FNA | |||
| Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
| Ingredient | ||||
| IngredientCode | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 80 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraalactieveingredient_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraalactieveingredient-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.50.3 Scenario 7 - MBH_300_magistraal90miljoennr-tmgs
| Toedieningsafspraak MBH_300_magistraal90miljoennr_TA-tmgs | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_magistraal90miljoennr_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T om 13:08 uur | |||
| Gebruiksperiode | Vanaf T, tot en met T + 30 dagen | |||
| Ingangsdatum | T | |||
| Einddatum | T + 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductCode | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.999.77.90000000.1.1111') | |||
| ProductNaam | Ureum 10% in eucerine cum aqua 100gr | |||
| Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
| Ingredient | ||||
| IngredientCode | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
| Sterkte | 10 gram per 100 gram | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag, cutaan | |||
| Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_magistraal90miljoennr_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_magistraal90miljoennr-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.50.4 Scenario 7 - MBH_300_vrijetekstproduct-tmgs
| Toedieningsafspraak MBH_300_vrijetekstproduct_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_vrijetekstproduct_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T - 1 dag om 15:50 uur | ||
| Gebruiksperiode | Vanaf T - 1 dag, gedurende 12 weken | ||
| Ingangsdatum | T - 1 dag | ||
| Gebruiksduur | 12 weken | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - ProductSpecificatie | |||
| ProductNaam | Jemperli 500 mg/ 10 mL | ||
| Omschrijving | Titel: Jemperli (Dostarlimab-gxly) 500 mg/10 mL | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per 3 weken 1 stuk, Intraveneus | ||
| Toedieningsweg | Intraveneus (code = '5' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per 3 weken 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_vrijetekstproduct_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_vrijetekstproduct-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.50.5 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.51 TEST Medicatiegegevens TA Scenarioset 10 (ZI)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Niesing | |||
| Identificatienummer | 999900845 [BSN] | |||
| Geboortedatum | 29 okt 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.51.1 Scenario 10.1 - MBH_300_ZINRvoorschrijven-tmgs
| Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_ZINRvoorschrijven_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 14:05 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 150 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_ZINRvoorschrijven_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_ZINRvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.51.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
1.52 TEST Medicatiegegevens TA Scenarioset 10 (ZI)
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | M. | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Niesing | |||
| Identificatienummer | 999900845 [BSN] | |||
| Geboortedatum | 29 okt 1985 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.52.1 Scenario 10 - MBH_300_ZINRvoorschrijven-tmgs
| Toedieningsafspraak MBH_300_ZINRvoorschrijven_TA-tmgs | |||
| Gegevenselement | Waarde | ||
| Identificatie | MBH_300_ZINRvoorschrijven_TA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| RegistratieDatumTijd | T om 14:05 uur | ||
| Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | ||
| Ingangsdatum | T | ||
| Einddatum | T + 150 dagen | ||
| Verstrekker | |||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | ||
| Geneesmiddel - primaire code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '16255429' in codeSystem 'G-Standaard ZI-nr') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE CF TABLET OMHULD 2,5MG (code = '2593866' in codeSystem 'G-Standaard HPK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
| Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
| Gebruiksinstructie | |||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | ||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| Doseerinstructie | 1 maal per dag 1 stuk | ||
| RelatieMedicatieafspraak | |||
| Identificatie | MBH_300_ZINRvoorschrijven_MA-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| MBH identificatie | MBH_300_ZINRvoorschrijven-tmgs (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
1.52.2 Bouwstenen
| Bouwstenen | |||
| Gegevenselement | Waarde | ||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | |||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | ||
| OrganisatieNaam | Apotheek De Gulle Gaper | ||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
